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1. SUMMARY 
Stem cells need to control the balance between proliferation and generation of differentiated 
cells in order to produce functional lineages. Studying the mechanisms that regulate this 
equilibrium is particularly relevant since defects in this balance can lead to tumorigenesis. 
We use the asymmetrically dividing Drosophila larval neuroblasts as a model to study how 
stem cells self-renew and form specific lineages. 
 
Larval neuroblasts of the central brain were thought to form rather simple lineages composed 
of a single stem cell (neuroblast) and of a few differentiating cells (ganglion mother cells – 
GMCs – and neurons). Here, we present a previously uncharacterized type of larval 
neuroblast that produces transit-amplifying cells, called secondary neuroblasts or 
Intermediate Neural Progenitors (INPs), which then produce GMCs and neurons. 
Additionally, we show that the lineages formed by these rare neuroblasts are particularly 
important because they produce a very large amount of neurons and are very sensitive to 
tumor formation. 
 
Before INPs can divide to produce GMCs, they need to mature – a process characterized by 
the successive expression of two transcription factors. To get a better understanding of INP 
biology, we made use of a genome-wide RNA interference (RNAi) screen, conducted 
specifically in Drosophila larval neuroblast lineages. In this screen, several genes led to 
overproliferation of progenitors upon knock down. Among them was the previously unstudied 
gene CG6049/barricade (barc). In this study, we characterize barc and show that it is 
important in neuroblast lineages for the production of neurons. Additionally, we show that 
upon barc RNAi knock down, most INPs remain in an immature state, demonstrating that 
Barc is a novel regulator of INPs. Barc is a nuclear protein composed of two RNA recognition 
motifs (RRMs) and a Barc/Tat-SF1 motif (BTS). Here, we show that only the second RRM of 
Barc is dispensable for the function of the protein in larval neuroblast lineages. Additionally, 
we demonstrate that Barc associates with DNA in vivo. Barc is the homologue of human Tat-
SF1 and yeast CUS2, two proteins that are involved in transcription elongation and splicing. 
To test whether Barc acts in a similar way, we established a cell culture system where we can 
efficiently knock down Barc and from which we prepared libraries of short capped RNAs and 
mRNAs. Analysis of these libraries will allow us to determine whether Barc acts by regulating 
transcription elongation and/or splicing. Finally, we generated a mutant allele and several 
rescue constructs that will enable us to study the effect of barc on cell cycle and cell fate, to 
identify the binding partners of Barc and to determine its binding pattern on DNA. 
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2. ZUSAMMENFASSUNG 
Eine einzige Stammzelle ist in der Lage eine komplette Zelllinie bestehend aus mehreren 
differenzierten Tochterzellen zu generieren. Um dies zu ermöglichen muss die Stammzelle 
das Gleichgewicht zwischen Selbsterneuerung und Differenzierung bewahren. Die 
Regulierung dieses Gleichgewichts ist sehr komplex und unterliegt einer sehr strengen 
Kontrolle. Geht dieses Gleichgewicht verloren, können Tumore entstehen. Deswegen ist es 
wichtig, jene Mechanismen zu verstehen, welchen die komplexe Regulierung dieses 
Gleichgewichts unterliegt. In dieser Studie untersuchen wir neuronale Stammzellen, 
sogenannte Neuroblasten, aus dem larvalen zentralen Nervensystem der Drosophila. 
Neuroblasten teilen sich asymmetrisch und können sich somit selbst erneuern und 
gleichzeitig differenzierte Tochterzellen generieren. 
 
Es wurde ursprünglich angenommen, dass Neuroblasten sehr „einfache“ Zelllinien 
generieren, welche aus einer Stammzelle (Neuroblast) und einigen wenigen differenzierten 
Zellen (Ganglion-Mutterzellen und Neuronen) bestehen. Diese Studie beschreibt einen bisher 
uncharakterisierten Neuroblastentyp, welcher zunächst intermediäre Vorläufernervenzellen 
generiert aus denen anschließend die Ganglion-Mutterzellen und Neuronen hervorgehen. 
Aufgrund dieser Vorläufernervenzellen, welche ebenso wie die Neuroblasten die Fähigkeit 
besitzen sich selbst zu erneuern, können sehr viel mehr Neuronen in kurzer Zeit generiert 
werden. Jedoch ist diese Art von Neuroblast genetische instabiler und somit sehr viel 
sensitiver in Bezug auf  die Ausbildung von Tumoren. 
 
Bevor sich intermediäre Vorläufernervenzellen teilen und Ganglion-Mutterzellen generiern, 
durchlaufen sie eine Art Reifeprozess. Dieser Reifeprozess zeichnet sich durch die sukzessive 
Expression zweier Transkriptionsfaktoren aus. Um die Biologie hinter diesen 
Vorläufernervenzellen besser zu verstehen, führten wir innerhalb der Neuroblast-Zelllinien 
eine genomweite Mutantenklassifizierung durch, wobei wir uns hierfür die RNA-Interferenz 
(RNAi) Bibliothek zu Nutze machten. Es konnten Gene identifiziert werden, welche bei 
Funktionsverlust zu einer vermehrten Anzahl von Neuroblasten führten. Darunter befand sich 
ebenfalls das bisher unbekannte Gen CG6049/Barricade (barc). Diese Studie befasst sich mit 
der Charakterisierung von Barc und zeigt dessen wichtige Bedeutung innerhalb der 
Neurogenese. Wird Barc mittels RNAi herunter reguliert, verweilen intermediäre 
Vorläuferzellen in einem unreifen Stadium, anstatt den Reifeprozess vollständig zu 
durchlaufen, um anschließend Neuronen zu generieren. Somit ist Barc ein neu identifizierter 
Regulator intermediärer Vorläuferzellen. Barc ist ein Kernprotein, welches zwei RNA 
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Erkennungsmotive und ein Barc/Tat-SF1 Motiv besitzt. Wir zeigen, dass, für die Funktion von 
Barc innerhalb der intermediären Vorläuferzellen, nur ein RNA Erkennungsmotiv notwendig 
ist. Ebenso demonstrieren wir in vivo, dass Barc mit der DNS interagiert. Barc ist das 
homologe Gen des humanen Tat-SF1 und dem CUS2 Gen aus Hefe. Beiden Genen konnte 
eine Rolle in der transkriptionalen Elongation und des RNA-Spleißmechanismus zugewiesen 
werden. Um festzustellen ob Barc eine ähnliche Funktion ausübt,  etablierten wir ein 
Zellkultursystem, in welchem wir Barc zunächst effizient ausschalten konnten und 
anschließend eine Bibliothek von ‚short-capped’ RNAs bzw. mRNAs herstellten. Die nähere 
Untersuchung dieser Bibliotheken wird uns Aufschluss darüber geben, ob und inwiefern Barc 
eine Rolle in der Regulierung der transkriptionalen Elongation und/oder des RNA-
Spleißmechanismus spielt. Ebenso generierten wir ein mutantes barc Allel und verschiedene 
transgene Barc-Konstrukte, mittels welcher wir die Funktion von Barc detaillierter analysieren 
können. Mit Hilfe dieser Konstrukte können wir zum einen untersuchen, ob Barc einen 
Einfluss auf den Zellzyklus oder das Zellschicksal hat,  zum anderen helfen sie uns, um 
Interaktionspartner von Barc zu identifizieren oder um das Barc-DNA Interaktionsmuster zu 
entschlüsseln. 
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3. GENERAL INTRODUCTION 
Development is the process whereby the zygote of a multicellular organism generates and 
precisely organizes into tissues and organs all cells of the forming and adult being. This 
challenging enterprise requires the tightly regulated production of a very large number of cell 
types that can be as different from each other as a neuron, a spermatozoid or a muscle cell. 
Stem cells play an important role in generating this cellular diversity during development and 
maintaining it in adult organisms. They are defined by their ability to self-renew and to 
generate daughter cells committed to differentiation. In other words, they have the capacity to 
divide asymmetrically, generating two cells with different fates. 
 
Over the last couple of decades, the fruit fly Drosophila melanogaster has emerged as a key 
model organism for studying development and has been instrumental in deciphering 
mechanisms of asymmetric divisions of stem cells and stem cell-like progenitors. In 
Drosophila, these cells can be found in a variety of tissues during the four successive phases 
of its life cycle: embryogenesis, larval stages, pupal stages – during which the larva undergoes 
metamorphosis, and adulthood. 
 
The first part of this general introduction presents the different modes of asymmetric cell 
division (ACD) in Drosophila. The second one focuses on neuroblasts, one of the best-
characterized models for ACD. The third one describes the basic mechanisms of ACD, while 
the final part summarizes evidences for the connection between defects in ACD and 
tumorigenesis in Drosophila. 
 
3.1. MODES OF ASYMMETRIC CELL DIVISION IN DROSOPHILA MELANOGASTER 
In Drosophila, ACD can be governed by either extrinsic or intrinsic cues (Fig. 1) (Knoblich, 
2008). These two different modes of ACD are explained in the following paragraphs. 
 
3.1.1. Extrinsic model 
The cell-extrinsic mode relies on a signal coming from surrounding cells forming the so-
called niche (Fig. 1A). This signal maintains the stem cell in a self-renewing state. 
Additionally, the niche signal sets up an axis of polarity ensuring that upon division the stem 
cell divides into a cell that remains in contact with the niche and a cell that moves away from 
it. While the cell remaining in contact with the niche maintains stem cell properties, the cell 
that moves away from the niche does no longer receive the signal and adopts a differentiating  
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Figure 1. Modes of asymmetric cell division: cell-extrinsic versus cell-intrinsic 
(A) In the cell extrinsic model, the stem cell needs a signal from the surrounding niche (purple) to 
maintain its self-renewing potential. Upon division, the cell dividing away from the niche (white cell) is 
no longer receiving this signal and differentiates, while the cell remaining in contact with the niche 
(green cell) retains a stem cell identity. (B) In the cell intrinsic model, a cellular axis of polarity is 
established prior to division by surrounding tissue. During mitosis, cell fate determinants (green) 
localize asymmetrically with respect to this axis of polarity. Upon cytokinesis, they segregate into one 
of the two daughter cells, where they act to ensure that the two daughter cells adopt different fates. 
Adapted from (Knoblich, 2008). 
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fate. This is the mode of ACD used by Drosophila germline stem cells for example (Knoblich, 
2008). 
 
3.1.2. Intrinsic model 
The cell-intrinsic mode a cellular axis of polarity triggers asymmetric localization of specific 
proteins – called cell fate determinants – during mitosis and their subsequent inheritance by 
only one of the two daughter cells (Fig. 1B). Cell fate determinants confer a specific fate to the 
cell that receives them, making it different from the other daughter cell. This mode of division 
is used by sensory organ precursors (SOPs) and neuroblasts, the precursors of the peripheral 
and the central nervous system (PNS and CNS), respectively (Knoblich, 2008). SOP cells 
cannot be considered stem cells since they do not self-renew and only undergo a series of 
four divisions to produce the four cells that compose an external sensory organ (for review, 
see (Neumuller and Knoblich, 2009)). Neuroblasts, however, are stem cell-like progenitors 
that self-renew and divide asymmetrically a large number of times to give rise to all neurons 
and glia of the central nervous system (for review, see (Knoblich, 2010)). For these reasons, 
over the last years, neuroblasts have become a very attractive model to study mechanisms of 
ACD and more generally stem cell biology in Drosophila. 
 
3.2. NEUROBLAST POPULATIONS IN DROSOPHILA 
Neuroblasts proliferate in two waves: the first one during embryogenesis to generate the 
embryonic CNS, the second one during larval stages to produce virtually all neurons of the 
adult CNS (Knoblich, 2008). 
 
3.2.1. Embryonic neuroblasts 
During embryogenesis, cells of the ventral neurectoderm delaminate and adopt a neuroblast 
fate (Knoblich, 2008). They divide several times along the apical-basal axis into a neuroblast 
that continues to proliferate and a smaller ganglion mother cell (GMC) that differentiate (Ito 
and Hotta, 1992). GMCs only divide once and produce two terminally differentiated neurons. 
These neuroblasts do not regrow between each division and nearly all of them enter 
quiescence after about 20 cycles (Wu et al., 2008). 
 
3.2.2. Larval neuroblasts 
The second wave of proliferation takes place in larval stages. At this time, the brain is 
composed of a ventral nerve cord (VNC) and of two brain lobes that each consist of a central 
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brain (CB) and an optic lobe (OL) (Fig. 2A). Larval neuroblasts, as opposed to embryonic 
neuroblasts, regrow between each division and can undergo a very large number of ACDs 
(Truman and Bate, 1988). They can be separated into three groups depending on their origin, 
pattern of proliferation and localization within the larval brain. The first group comprises 
neuroblasts of the CB (about 85 per lobe) and of the VNC (30 per hemisegment), which 
correspond to embryonic neuroblasts that re-entered the cell cycle (Fig. 2A) (Ito and Hotta, 
1992; Truman and Bate, 1988). They are responsible for producing the vast majority of 
neurons of the adult central brain, the thoracic ganglia and the abdominal ganglia (Ito and 
Hotta, 1992; Truman and Bate, 1988). The second group is formed by the 8 mushroom body 
neuroblasts (4 per brain lobe, Fig. 2A). Like CB and VNC neuroblasts they are generated in 
the embryo, however mushroom body neuroblasts start proliferating earlier – and stop later, 
forming specific neurons called kenyon cells that are involved in learning and memory (Ito 
and Hotta, 1992; Ito et al., 1997). Finally, the third group consists of newly born neuroblasts 
that originate from the OL neuroepithelium to produce the neurons of the visual processing 
centers of the brain (Fig. 2A) (Egger et al., 2007). 
 
Because of their strong proliferation potential, large number and importance for brain 
development, CB neuroblasts have emerged as a model of choice to study ACD and self-
renewal and are the main focus of this study. In this introduction they are deliberately 
considered to be a homogenous population (for further subdivision and characterization of 
this group of neuroblasts, please refer to chapter I). CB neuroblasts form lineages by dividing 
asymmetrically into a neuroblast and a GMC that then generates two neurons through a 
terminal division (Fig. 2B). The next few paragraphs describe the basic mechanisms 
underlying neuroblast ACD. 
 
3.3. MECHANISM OF ASYMMETRIC CELL DIVISION IN DROSOPHILA NEUROBLASTS 
3.3.1. Cell fate determinants  
In neuroblast ACD, the generation of two daughter cells with different fates is ultimately 
mediated by the asymmetric segregation into the GMC of a specific set of proteins called cell 
fate determinants: Numb, Prospero (Pros) and Brain tumor (Brat) (Fig. 2C) (Spana et al., 1995; 
Hirata et al., 1995; Knoblich et al., 1995; Spana and Doe, 1995; Betschinger et al., 2006; 
Bello et al., 2006; Lee et al., 2006c). All three proteins are essential to specify GMC fate (see 
section 3.4). Numb is an endocytic protein first identified in SOPs, where it was shown to 
down-regulate Notch signaling via interaction with Notch and α-adaptin, a protein involved  
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Figure 2. Drosophila larval neuroblast lineages and mechanism of asymmetric cell division 
(A) The larval brain is composed of a ventral nerve cord (VNC) and of two brain lobes that can be 
further subdivided into optic lobe (OL) and central brain (CB). (B) Each CB neuroblast lineage is 
composed of a single large neuroblast, a few smaller GMCs and several small neurons. (C) Principle of 
ACD in neuroblast. In mitosis, the apical aPKC/Par6/Baz complex plays two essential roles. One is to 
restrict localization of Pon, Mira, Brat, Numb and Pros to the basal cortex. The other one is to control 
alignment of the mitotic spindle via Insc and the Gai/Pins/Mud complex. The coordination of these two 
events enables segregation of the determinants into the smaller GMC where they trigger differentiation, 
whereas the bigger cell remains a neuroblast and continues to proliferate. Adapted from (Knoblich, 
2010). (D) Phosphorylation cascade that controls asymmetric localization of Numb. In interphase, 
aPKC forms an inactive complex with Par-6 and Lgl. In mitosis, Par6 is phosphorylated by Aur-A, 
which triggers autophosphorylation of aPKC. Activated aPKC phosphorylates Lgl, which leaves the 
complex and is replaced by Baz. This active Par complex is able to phosphorylate Numb to release it 
from the apical cortex, therefore limiting its localization to the basal cortex of the neuroblast. Adapted 
from (Wirtz-Peitz et al., 2008). (E) Control of spindle alignment. In mitosis, the Gai/Pins/Mud complex 
connects microtubules of the mitotic spindle to the Par complex and the apical cortex via Insc. 
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in receptor-mediated endocytosis (Rhyu et al., 1994; Guo et al., 1996; Santolini et al., 2000; 
Berdnik et al., 2002). It is thought that Numb also inhibits Notch signaling in the GMC. Pros 
is a homeodomain transcription factor that is cytoplasmic in the neuroblast but enters the 
nucleus once in the GMC (Hirata et al., 1995; Knoblich et al., 1995; Spana and Doe, 1995). 
In the GMC, Pros acts both as an activator and an inhibitor of transcription and regulates a 
large set of genes involved in neuroblast self-renewal, cell cycle control and neuronal 
differentiation (Choksi et al., 2006; Southall and Brand, 2009). Unlike for Numb and Pros, the 
precise function of Brat remains elusive (Betschinger et al., 2006; Bello et al., 2006; Lee et al., 
2006c). Brat belongs to the same family of proteins than Mei-P26 and Dappled, which have 
both been shown to regulate cell growth and proliferation (Rodriguez et al., 1996; Page et al., 
2000; Neumuller et al., 2008). Members of this family share a similar structure, containing 
one or more N-terminal zinc-finger like B boxes, a coiled-coil motif and a C-terminal NHL 
domain (Slack and Ruvkun, 1998; Betschinger et al., 2006). In the embryo, Brat is involved in 
establishment of the anterior-posterior axis by binding to Nanos and Pumilio and repressing 
translation of the posterior gene hunchback (Sonoda and Wharton, 2001). However, 
phenotypes and expression patterns of Nanos, Pumilio and Hunchback cannot explain the 
function of Brat in larval neuroblasts (Knoblich, 2008). Therefore, the precise mechanism by 
which Brat inhibits cellular growth in GMCs is currently unclear. 
 
All three cell fate determinants are transported by adaptor proteins that also localize 
asymmetrically during mitosis and segregate into the GMC. Pros and Brat bind to the coiled-
coil protein Miranda (Mira), whereas Numb binds to Partner of Numb (Pon) (Lee et al., 
2006c; Betschinger et al., 2006; Ikeshima-Kataoka et al., 1997; Shen et al., 1997). The role of 
Mira in asymmetric segregation of Brat and Pros is essential, since in mira mutants both 
determinants become uniformly cytoplasmic and segregate equally into both daughter cells 
(Betschinger et al., 2006; Lee et al., 2006c; Shen et al., 1997; Ikeshima-Kataoka et al., 1997). 
The case of Pon is more complex, because in pon mutant neuroblasts, asymmetric 
localization of Numb is delayed but is then rescued by end of mitosis (Lu et al., 1998). This 
observation indicates that Pon facilitates Numb asymmetric segregation but is not absolutely 
crucial for it. 
 
3.3.2. Role of the Par complex 
Brat, Numb, Pros and their adaptor proteins Mira and Pon localize to the basal cortex during 
mitosis and are inherited by the GMC only (Fig. 2C). This process depends on the conserved 
Par complex – Par stands for “Partitioning defective mutants” – that was originally identified 
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in C. elegans and which plays a key role in cell polarity in a variety of cell types and 
organisms (Suzuki and Ohno, 2006; Ohno, 2001; Goldstein and Macara, 2007). The active 
Drosophila Par complex is composed of the atypical Protein Kinase C (aPKC) and the PDZ 
domain-containing proteins Par-6 and Bazooka (Baz, also called Par-3) (Suzuki and Ohno, 
2006; Goldstein and Macara, 2007). In mitosis, these three proteins are found at the apical 
cortex (Wodarz et al., 1999; Schober et al., 1999; Wodarz et al., 2000; Rolls et al., 2003). In 
Drosophila neuroblasts mutant for either aPKC, Par-6 or Baz, the other two proteins are 
mislocalized, cell fate determinants localize uniformly around the cell cortex and mitotic 
spindle alignment becomes random (Knoblich, 2008). Indeed, the Par complex has two main 
functions during ACD of neuroblasts: to restrict localization of cell fate determinants to the 
basal cortex and to control spindle alignment (Fig. 2C-E). 
 
3.3.3. Asymmetric segregation of cell fate determinants 
The precise mechanism controlling basal localization of cell fate determinants remained a 
mystery for a long time. Recently, a phosphorylation cascade has been identified that controls 
this process and is summarized below (Fig. 2D) (Wirtz-Peitz et al., 2008). In interphase, aPKC 
forms an inactive apical complex with Par-6 and the cytoskeletal protein Lethal (2) giant 
larvae (Lgl). Upon entry in mitosis, the kinase Aurora A (AurA) phosphorylates Par-6, which 
leads to the activation of aPKC via autophosphorylation. aPKC in turn phosphorylates Lgl, 
which allows its release from the apical complex and its replacement by Baz. This subunit 
exchange triggers a modification of aPKC substrate specificity that leads to the 
phosphorylation of Numb and its release from the apical cortex. This model for basal 
localization of Numb during ACD is thought to be responsible for Brat and Pros asymmetric 
localization as well, since Mira is also a substrate of aPKC and that aPKC phosphorylation is 
important for Mira localization during neuroblast ACD (Wirtz-Peitz et al., 2008; Atwood and 
Prehoda, 2009). 
 
3.3.4. Control of spindle alignment 
For asymmetric determinants to be inherited by the GMC, the mitotic spindle has to be 
aligned with the axis of polarity (Fig. 2C&E). This is achieved by interaction of the active Par 
complex with the apically localized adaptor protein Inscuteable (Insc), via Baz (Kraut et al., 
1996; Schober et al., 1999; Wodarz et al., 1999). This interaction has two main 
consequences. On the one hand Insc stabilizes the Par complex (Wodarz et al., 2000; 
Wodarz et al., 1999; Petronczki and Knoblich, 2001). On the other hand Insc binds to Partner 
of Inscuteable (Pins) and the G protein subunit αi (Gαi), which form a complex with the 
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NuMA-related Mushroom body defect (Mud) protein (Parmentier et al., 2000; Schaefer et al., 
2000; Bowman et al., 2006; Izumi et al., 2006; Siller et al., 2006). The Gαi-Pins-Mud 
complex is anchored to the plasma membrane via N-myristoylated Gαi and to microtubules 
of the mitotic spindle via Mud (Sprang, 1997; Bowman et al., 2006; Izumi et al., 2006; Siller 
et al., 2006). Interaction of the Gαi-Pins-Mud complex with Insc, and therefore the Par 
complex, allows precise alignment of the mitotic spindle with the cellular axis of polarity to 
ensure that determinants are segregated into the GMC only. This is crucial for proper ACD 
since in neuroblasts where spindle orientation is randomized, such as in mud mutants, the 
fate of the two daughter cells is affected and ultimately dictated by the ratio of Par complex 
versus determinants that is inherited by each cell (Cabernard and Doe, 2009). 
 
3.4. DROSOPHILA NEUROBLAST ASYMMETRIC DIVISION AND TUMORIGENESIS 
3.4.1. Connection between ACD and tumor formation 
Studies conducted in Drosophila in the 1960s and 1970s led to the identification of a set of 
five genes – brat, lgl, discs large (dlg), lethal(2)giant discs (lgd) & lethal(3)malignant brain 
tumor (l(3)mbt) – which, when mutated, provoked tumorous overgrowth in larval brains as 
well as in other tissues (for review, see (Gateff, 1994)). Interestingly, when fragments of these 
brains were transplanted into the abdomen of wild-type flies, they continued to proliferate, 
failed to differentiate, showed abnormal morphologies, invaded other tissues and ultimately 
killed their host. Among these five tumor suppressor genes, three were recently shown to play 
a role in ACD: brat, lgl and dlg (Ohshiro et al., 2000; Peng et al., 2000; Albertson and Doe, 
2003; Betschinger et al., 2006; Bello et al., 2006; Lee et al., 2006c). The discovery that 
defects in ACD could lead to such a dramatic phenotype first came as a surprise. Although it 
was not entirely clear why this could be, a simple explanation of the brat mutant phenotype, 
for example, is that the smaller cell that should normally receive Brat is unable to differentiate 
and instead proliferates abnormally, leading to the formation of a tumor (Fig. 3A&B). 
 
3.4.2. The Drosophila larval neuroblast as a model for cancer cell biology 
In addition to the tumor suppressors lgl, dlg and brat, many genes that play a role in ACD 
have been shown in recent years to prevent neuroblast overproliferation. Brains mutant for 
mira, numb and pros form transplantable tumors that can reach a 100 times their original 
size, invade other tissues, show centrosome alterations and become aneuploid (Caussinus 
and Gonzalez, 2005). Additionally, formation of tumors has been described in mutants for the 
mitotic kinases AurA and Polo (another kinase involved in ACD), mutants with aberrant  
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Figure 3. Defects in neuroblast ACD can lead to overproliferation and tumorigenesis 
(A) In a dividing wild type neuroblast, the Par complex localizes apically whereas determinants such as 
Brat localize to the basal cortex. Segregation of Brat in the smaller cell triggers differentiation of this 
cell, whereas the bigger cell continues to proliferate. (B) In the absence of Brat, the smaller cell is 
unable to properly differentiate and this leads to overproliferation of self-renewing cells at the expense 
of differentiating cells, thereby generating a tumor. 
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spindle orientation and even mutants with an excess of centrosomes (Lee et al., 2006a; Wang 
et al., 2006; Wang et al., 2007; Bowman et al., 2006; Siller et al., 2006; Izumi et al., 2006; 
Cabernard and Doe, 2009; Kitajima et al., 2010; Basto et al., 2008; Castellanos et al., 2008). 
Conversely, mutations in the apically localized aPKC or Pins lead to fewer neuroblasts rather 
than overproliferation (Lee et al., 2006b). 
 
The compelling observation that mutations in many genes involved in ACD can cause 
neuroblast overproliferation and formation of tumors has recently made the larval neuroblast 
a very potent model to study the relationship between ACD, self-renewal and tumorigenesis. 
Even more so in the light of the recently formulated “cancer stem cell hypothesis” which 
suggests that many human tumors arise from and are maintained by very small populations of 
stem cells (Reya et al., 2001). 
 
3.5. STRUCTURE AND AIM OF THIS STUDY 
This study is presented as two chapters introduced below. 
 
Chapter I 
It was long thought that CB neuroblasts form a homogeneous population generating rather 
simple lineages. The first chapter describes a previously unrecognized population of CB 
neuroblasts that form much more complex lineages, and their implication in tumor formation.  
 
Chapter II 
In order to identify novel genes regulating neuroblast self-renewal and lineage progression in 
the larval brain, a genome-wide RNAi screen was conducted in our laboratory. One of the 
candidate genes that caused an overproliferation phenotype is the previously unstudied gene 
CG6049/barricade. The second chapter focuses on the characterization of this gene, 
exploring its role in regulating neuroblast lineages. 
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4. CHAPTER I – THE TUMOR SUPPRESSORS BRAT AND NUMB REGULATE 
TRANSIT-AMPLIFYING NEUROBLAST LINEAGES IN DROSOPHILA 
 
This work was published as: 
Bowman SK, Rolland V, Betschinger J, Kinsey KA, Emery G and Knoblich JA. The Tumor 
Suppressors Brat and Numb Regulate Transit-Amplifying Neuroblast Lineages in Drosophila. 
Developmental Cell. 2008; 14(4): 535-46 
Please note that for sake of clarity, the abstract of this paper has been removed. 
4.1. CONTRIBUTIONS 
The author of this thesis contributed Figure 8A to 8D and 8H to 8J – corresponding to Figure 
5A to 5D and 5H to 5J of the published paper. Sarah Bowman contributed all other figures, 
tables and supplementary data of this chapter. Joerg Betschinger suggested the concept of a 
transit amplifying neuroblast lineage and made some initial observations about these 
neuroblasts. Gregory Emery first identified the lgd overproliferation phenotype. Kaolin Kinsey 
built the mathematical model of the type 2 lineage. Juergen Knoblich and Sarah Bowman 
designed experiments and wrote the manuscript. 
4.2. INTRODUCTION 
The development of the Drosophila central nervous system has become the subject of 
intensive investigation as a model for the regulation of self-renewal in stem cell lineages (Chia 
et al., 2008). Neuroblasts are specified in the embryo, and they begin dividing in a self-
renewing manner to produce neurons used by the larva. In larval and pupal stages, the 
divisions continue and produce the neurons of the adult fly. It has long been accepted that all 
neuroblasts express the neural precursor gene asense (ase) (Brand et al., 1993; Jarman et al., 
1993) and divide asymmetrically to self-renew and produce a small daughter cell, the 
ganglion mother cell (GMC). The GMC divides terminally into two neurons or glia. 
 
During each neuroblast division, an axis of polarity is established by the activity of the Par 
complex, a conserved protein complex consisting of Par-3/Bazooka (Schober et al., 1999; 
Wodarz et al., 1999), Par-6 (Petronczki and Knoblich, 2001), and atypical Protein Kinase C 
(aPKC) (Rolls et al., 2003; Wodarz et al., 2000). The Par complex has two major functions. 
The first function is to recruit a protein called Inscuteable (Insc) which maintains the polarity 
of the Par complex and thereby the polarity of the neuroblast (Schober et al., 1999; Wodarz 
et al., 1999). Insc also directs the mitotic spindle to align along the axis of polarity (Kraut et 
al., 1996). The second function of the Par complex is to promote the localization of cell fate 
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determinants to the opposite pole of the neuroblast (Betschinger et al., 2003). The cell fate 
determinants segregate exclusively into the GMC at telophase and act to specify GMC fate. 
They include the Notch repressor Numb (Knoblich et al., 1995), the transcription factor 
Prospero (Pros) (Hirata et al., 1995; Knoblich et al., 1995), and the NHL-domain protein Brain 
tumor (Brat) (Bello et al., 2006; Betschinger et al., 2006; Lee et al., 2006c). In the GMC, 
Numb, Pros, and Brat are all thought to inhibit self-renewal and promote cell cycle exit and 
differentiation. Numb probably does this by promoting endocytosis of the Notch receptor, 
making levels of Notch signaling lower than in the neuroblast (Berdnik et al., 2002; Wang et 
al., 2006). Pros enters the GMC nucleus after degradation of its cortical anchor protein 
Miranda (Mira), represses expression of cell cycle genes and activates genes required for 
terminal differentiation (Choksi et al., 2006; Ikeshima-Kataoka et al., 1997; Li and Vaessin, 
2000; Shen et al., 1997). Brat may act to prevent cell growth (Betschinger et al., 2006; Frank 
et al., 2002). Consistent with the functions of these genes in repressing growth and self-
renewal, loss of brat, numb, or pros in the larva results in neuroblast lineages that escape 
differentiation. This causes overgrowth characterized by the overproduction of neuroblast-like 
cells at the expense of differentiated neurons (Bello et al., 2006; Betschinger et al., 2006; Lee 
et al., 2006a; Lee et al., 2006c; Wang et al., 2006). Although brain tissue mutant for numb, 
pros, or brat all share similar terminal phenotypes, the precise cellular events initiating the 
overgrowth are unknown. Close analysis of the brat phenotype indicates that the overgrowing 
cells arise in a specific location in the central brain (Bello et al., 2006; Betschinger et al., 
2006), suggesting that some cells are particularly sensitive to loss of brat. In this study, we 
demonstrate that these cells comprise a previously uncharacterized neuroblast lineage with a 
transit-amplifying pool of intermediate progenitors. Unlike any known Drosophila 
neuroblasts, the neuroblasts generating this lineage repress Ase. We show that Brat and Numb 
act to promote maturation of intermediate progenitors. In the absence of these proteins, 
maturation fails to take place, immature progenitors begin to divide, and their progeny do not 
differentiate. Our data suggest that mitosis in an immature intermediate progenitor can initiate 
tumorous overgrowth.  
 
4.3. RESULTS 
4.3.1. brat overgrowth originates in Ase- neuroblast lineages  
Mutation in brat leads to dramatic overproduction of neuroblasts at the expense of neurons 
(Bello et al., 2006; Betschinger et al., 2006; Lee et al., 2006c). The phenotype is thought to 
arise from misregulated neuroblast division, but not all central brain neuroblasts are equally  
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Figure 4. brat overgrowth originates in PAN neuroblast lineages 
(A-I) Immunostainings of third instar brains labeled with indicated markers (gray boxes). For each 
genotype, an overview of the brain lobe and a detail of neuroblast lineages are shown. (A-B) Wild type 
brains contain PAN neuroblasts with long lineages of Ase+ progeny (A, A’ outline); ectopic expression 
of Ase eliminates both (B, B’ outline). (C, C’) a brat zygotic mutant brain is overgrown with PAN 
neuroblasts. (D-G) Brains with GFP reporting insc-Gal4 expression. Control brains are well organized 
and contain PAN neuroblasts (D, D’ arrowhead). Brat knockdown results in disorganized overgrowth 
with ectopic PAN neuroblasts (E, E’ arrowheads). Expressing Ase in all neuroblasts eliminates PAN 
neuroblasts (F, F’). Ectopic expression of Ase prevents the overgrowth normally caused by Brat 
knockdown (G, G’). (H-I) Brains with GFP reporting ase-Gal4 expression. Neither control (H, H’) nor 
Brat knockdown brains (I, I’) show disorganized overgrowth phenotypes. Scale bars: A-I, 50 µm; A’-I’, 
10 µm. 
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affected by loss of Brat (Bello et al., 2006; Betschinger et al., 2006). To find molecular 
markers for the sensitive subpopulation, we examined known neuroblast markers and 
checked for differential expression among small groups of central brain neuroblasts. The 
expression pattern of the transcription factor Ase fit this profile and we selected it for further 
analysis. Ase is a member of the achaete-scute complex (AS-C), a quartet of genes involved in 
specifying neural precursor cells. Expression of Ase typically begins after the remaining three 
members of the AS-C have acted together with other genes to specify neural precursor fate, 
and it persists after the precursor starts to divide (Brand et al., 1993).  
 
Ase protein is present in the majority of central brain neuroblast nuclei, but absent from eight 
neuroblasts per brain lobe (Fig. S1). Due to their position on the posterior side of the brain, 
we refer to these neuroblasts as Posterior Asense-Negative (PAN) neuroblasts. They may 
tentatively be assigned to the dorsoposterior medial group of neuroblast lineages (Pereanu 
and Hartenstein, 2006) because of their location. Six medial PAN neuroblasts produce long 
chains of Ase+ progeny cells with high levels of cortical actin, while Ase+ neuroblasts 
typically have a small number of closely associated Ase+ progeny (Fig. 4A). Two additional 
PAN neuroblasts generate progeny that populate more interior brain regions (Fig. S1, and data 
not shown). Because they are more abundant and easier to identify, we focused our analysis 
on the medial PAN neuroblasts. 
 
Since Ase is thought to be expressed in all Drosophila neural precursor cells after their 
specification from the neuroepithelium (Brand et al., 1993) as well as in the neural precursors 
of other insects (Wheeler et al., 2003), its absence in a subset of neuroblasts is surprising. To 
test whether downregulation of Ase in the PAN neuroblasts allows production of the long 
chains of Ase+ progeny, we ectopically expressed Ase in all neuroblasts. For this, we used the 
Gal4 line 1407 inserted in the insc promoter (Betschinger et al., 2006), hereafter referred to as 
insc-Gal4. Ectopic Ase expression eliminates all Ase- neuroblasts and all lineages with long 
chains of Ase+ progeny containing high levels of cortical actin (Fig. 4B). Since high levels of 
Ase could potentially interfere with specification of neuroblast identity during embryogenesis, 
we prevented this by using the temperature sensitive Gal4 inhibitor Gal80ts to limit Ase 
overexpression to the larval stages. This also eliminated PAN neuroblast lineages (PAN 
lineages; data not shown). We conclude from these experiments that ectopic expression of 
Ase eliminates PAN lineages, perhaps by transforming PAN neuroblasts to Ase+ neuroblasts 
that produce fewer progeny. 
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PAN neuroblasts are found on the dorsal-posterior central brain, the region thought to cause 
the brat overgrowth phenotype (Bello et al., 2006; Betschinger et al., 2006). To investigate 
whether the brat phenotype originates in PAN lineages, we tested whether brat loss of 
function could cause brain overgrowth in their absence. For this, we overexpressed Ase with 
insc-Gal4 and simultaneously knocked down brat using transgenic RNAi. In control brains, 
PAN lineages are clearly visible in the posterior medial region (Fig. 4D, 4D’). Brat knockdown 
significantly reduces the amount of Brat protein (Fig. S2), causing disorganized overgrowth 
with many ectopic PAN neuroblasts (45.6 ±  6.0 PAN neuroblasts, n=5 brain lobes; Fig. 4E, 
4E’). As described above, overexpression of Ase eliminates the PAN lineages (Fig. 4F, 4F’). 
Simultaneous overexpression of Ase and brat knockdown does not generate either the 
overgrowth or the ectopic PAN neuroblasts seen with brat RNAi alone (0.0 ± 0.0 PAN 
neuroblasts, n=6 brain lobes; Fig. 4G, 4G’), even though Brat protein is reduced to similar 
levels (Fig. S2). This indicates that PAN lineages are required for the brat overgrowth 
phenotype. If the brat phenotype arises in the PAN lineages only, brat knockdown in Ase+ 
neuroblasts should have no effect. To test this, we knocked down brat using ase-Gal4. ase-
Gal4 is expressed in all central brain neuroblasts except for the eight PAN neuroblasts (Fig. 
S1, 4H, 4H’). Notably, the Ase+ progeny of the PAN lineage express ase-Gal4 at low or 
undetectable levels; this may be because transcriptional control of ase in these cells lies 
outside the 2kb genomic fragment used to make ase-Gal4. While knockdown of Brat with 
ase-Gal4 significantly reduces Brat protein levels (Fig. S2), it does not cause overgrowth of 
Ase+ neuroblasts (Fig. 4I, 4I’). We conclude from these data that PAN neuroblasts are the 
neuroblast subpopulation affected by mutation in brat, and the PAN lineages produce the 
neoplastic transformation seen in brat mutants. Correspondingly, overgrown brat mutant 
brains consist almost entirely of Ase- neuroblasts (Fig. 4C). 
 
4.3.2. PAN lineages produce intermediate progenitors 
To investigate why brat affects Ase- neuroblasts specifically, we analyzed PAN lineages in 
greater detail using the MARCM system (Lee et al., 1999). This method allows the generation 
of wild type or mutant neuroblast clones that express membrane-bound GFP in an otherwise 
wild type, GFP-negative background. For this analysis, we induced clones at 48 hours after 
larval hatching (ALH), and examined them either 24 or 48 hours later. Ase+ neuroblast clones 
always contain one Ase+ neuroblast, several Ase+ daughter cells, and many Elav+ neurons 
(Fig. 5A, 5B). The major difference between clones that have been developing for 24 hours 
(24-hr clones) and clones that have been developing for 48 hours (48-hr clones) is an increase 
in Elav+ neurons (Table 1B). Occasionally, we observed a single Ase+ progeny cell dividing  
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Figure 5. PAN lineages produce intermediate progenitors 
(A-D) Immunostainings of MARCM clones in central brain neuroblasts labeled with indicated markers 
(gray boxes). p-H3: phospho histone H3. Neuroblast clones are three-dimensional structures, so two 
separate optical sections from a Z-stack through each clone are shown. The most superficial section is 
labeled 0 µm. (A-D) Neuroblast clones are reported by GFP expression. In 24-hr (A) and 48-hr clones 
(B), Ase+ neuroblasts produce Ase+ and Elav+ progeny. A single Ase+ cell divides symmetrically in size 
and adjacent to the neuroblast (B’, arrowhead). In 24-hr PAN clones, the neuroblast produces Ase- 
progeny and Ase+ progeny, but almost no Elav+ progeny (C). 48-hr PAN clones contain a small number 
of Ase- cells, and large numbers of Ase+ and Elav+ cells (D). All mitotic cells are Ase+, several are far 
away from the neuroblast, and one divides asymmetrically in size (D’, arrowhead). Scale bars: 10µm. 
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symmetrically in size, always closely associated with the neuroblast (Fig. 5B’). These 
observations are consistent with a standard neuroblast lineage, where an Ase+ neuroblast 
produces an Ase+ GMC that divides terminally to produce 2 Elav+ neurons. 
 
By contrast, in 24-hr PAN neuroblast clones (PAN clones), the neuroblast produces almost 
exclusively Elav- progeny (Fig. 5C, Table 1B). Some daughter cells are Ase-, but most are 
Ase+. In 48-hr clones, the PAN neuroblast produces more than twice as many cells as an Ase+ 
neuroblast (48-hr Ase+ clones 57.6 ± 3.8 progeny, n=5 clones; 48-hr Ase- clones 131.4 ± 2.6 
progeny, n=5 clones). Ase- progeny are never in mitosis, but there are around 9 mitotic Ase+ 
progeny per clone (9.2 ± 0.6 cells per Ase- clone, n=4 clones) – some dividing as many as 11 
cell diameters away from the neuroblast (Fig. 5D, 5D’). These observations show that a PAN 
neuroblast can produce more progeny than an Ase+ neuroblast in the same time period, and 
in contrast to an Ase+ lineage, the progeny of the PAN neuroblast will enter mitosis far away 
from their mother. 
 
The increased number of progeny in the PAN neuroblast clones could be produced either by 
more frequent divisions of the PAN neuroblasts, or by multiple rounds of mitosis in the Ase+ 
daughter cells. To distinguish these possibilities, we calculated the mitotic index of PAN 
neuroblasts. We reasoned that an increased rate of PAN neuroblast division would result in 
an observable increase in the fraction of mitotic PAN neuroblasts. Throughout larval 
development, the mitotic index of PAN neuroblasts and Ase+ neuroblasts are similar (Table 
1A), so the increased number of progeny is unlikely to arise from more frequent PAN 
neuroblast division. These results, together with the large number of mitotic Ase+ daughters, 
suggest that the Ase+ progeny divide multiple times to produce the large numbers of cells 
observed in PAN neuroblast clones. This contrasts sharply with a standard neuroblast lineage, 
where neuroblast daughters always divide terminally. The presence of intermediate 
progenitors in the medial central brain would explain why this region contains high numbers 
of small, BrdU-incorporating cells (Ito and Hotta, 1992). 
 
4.3.3. PAN lineages contain transit-amplifying secondary neuroblasts 
How does an Ase- neuroblast produce Ase+ intermediate progenitors? To test whether PAN 
neuroblasts stochastically produce Ase- and Ase+ daughters, we examined PAN clones with 
telophase neuroblasts. All PAN neuroblasts observed generate Ase- daughters (n=7 telophase 
neuroblasts, Fig. S3A). This indicates that the Ase+ progeny in the clone must arise from these  
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A: Mitotic index of central brain neuroblasts 
 Ase+ PAN 
stage total NB mitotic NB mitotic index total NB mitotic NB mitotic index 
48 hr ALH 260 71 27% 84 18 21% 
72 hr ALH 276 66 24% 81 23 28% 
96 hr ALH 491 139 28% 94 20 22% 
 
B: Composition of wild type neuroblast clones 
clone type n 
Ase- Elav- 
(2º NB) 
Ase+ Elav- 
(2º NB and GMC) 
Ase- Elav+ 
(neuron) 
divisions 
(GMC+neuron/2) 
Ase+ 24-hr 13 0 7.5 ± 0.6 20.3 ± 1.2 17.7 ± 0.7 
Ase+ 48-hr 5 0 5.4 ± 0.5 52.2 ± 3.6 31.5 ± 2.0 
PAN 24-hr 9 3.4 ± 0.2 21.0 ± 1.6 2.1 ± 0.7 ND 
PAN 48-hr 5 2.2 ± 0.2 47.0 ± 3.1 82.2 ± 4.8 ND 
 
clone type n 
Ase- nPros- 
(2º NB) 
Ase+ nPros- 
(2º NB) 
Ase+ Pros+ 
(GMC) 
Ase- Pros+ 
(neuron) 
PAN 24-hr 5 4.0 ± 0.3 9.4 ± 0.5 7.8 ± 1.2 2.2 ± 0.6 
PAN 48-hr 4 3.3 ± 0.3 27.5 ± 1.7 22.8 ± 2.7 90.3 ± 3.8 
 
C: Composition of 24-hr brat192 or numb15 neuroblast clones 
clone type n Elav- Elav+ 
divisions 
(GMC+neuron/2) 
brat, Ase+  10 8.3 ± 0.6 14.3 ± 2.3 15.5 ± 1.1 
brat, PAN 10 10.0 ± 0.7 0.0 ± 0.0 ND 
numb, PAN 11 11.5 ± 1.5 0.0 ± 0.0 ND 
 
Table 1. (A) Staged larvae were stained for Ase, phalloidin, and phospho histone H3 to quantify the 
mitotic index. (B) Cell composition of MARCM clones stained for Ase and Elav (upper part) or Ase and 
Pros (lower part). All cells in the clone were counted and then tabulated according to the indicated 
marker profile. For PAN neuroblasts, we focused on the medial population. nPros: nuclear Pros. (C) 
Cell composition of MARCM clones stained for Ase and Elav. Error here and above is standard error of 
the mean. ND: not determined because GMCs and/or neurons are not specifically detected. 
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Ase- cells. We next tested whether the Ase- daughters become quiescent or remain Ase- for a 
long time. For this, we made use of the observation that daughter cell position correlates with 
time of birth: recently born daughters are near the primary neuroblast, while daughters born 1 
or 2 days ago (or descendents of those daughters) tend to be several cell diameters away 
(compare figure 5C and 5D). If Ase- daughters remain Ase- for longer than 24 hours, we 
would expect to see them far from the PAN neuroblast in 48-hr clones. We quantified this 
distance and found that 20% of Ase- daughters are one cell diameter away from the PAN 
neuroblast, and 80% of them directly contact it (n=9 48-hr clones and 20 Ase- daughters). 
The position near the PAN neuroblast suggests that all Ase- daughters were born relatively 
recently, and the absence of Ase- daughters in positions occupied by older progeny indicates 
that Ase- status is not maintained. The most likely possibility is that these cells become Ase+. 
This data does not directly rule out the possibility that Ase- daughters are quiescent. We 
therefore stained PAN clones with anti-Cyclin E (CycE). CycE marks some Ase- daughter 
nuclei, indicating they are cycling cells (Fig. S3B). We conclude that the PAN neuroblast 
produces Ase- daughters that remain Ase- for a limited period of time before becoming Ase+ 
intermediate progenitors. 
 
To determine the identity of the Ase+ intermediate progenitors, we stained 48-hr neuroblast 
clones with anti-Pros and anti-Ase antibodies. Pros is present in the nuclei of GMCs and 
neurons but never nuclear in neuroblasts (Bello et al., 2006; Betschinger et al., 2006). 
Correspondingly, in Ase+ neuroblast clones, neuroblasts appear Ase+Pros-, GMCs appear 
Ase+Pros+ and neurons Ase-Pros+ (Fig. 6A). Unlike the daughters of Ase+ neuroblasts, many 
daughters of PAN neuroblasts do not import Pros to the nucleus. Of these daughters, 2 or 3 
are Ase-, and many more are Ase+ (Fig. 6B at 0 µm, Table 1B). There are also Ase+Pros+ 
GMCs (Fig. 6B at –1 µm, Table 1B). Absence of nuclear Pros is consistent with a neuroblast-
like cell type. To investigate this further, we checked the expression of neuroblast markers 
Deadpan (Dpn) and CycE in the PAN lineage. Dpn and CycE are typically confined to one or 
two adjacent daughters in Ase+ neuroblast lineages (data not shown, (Bello et al., 2006; 
Betschinger et al., 2006; Lee et al., 2006c)). In PAN lineages, Dpn and CycE maintain high 
levels of expression in large numbers of progeny (Fig. 6C, 6D). This implies that many of 
these daughters could be secondary neuroblasts. 
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Figure 6. PAN lineages contain secondary neuroblasts 
Immunostainings of larval brains labeled with indicated markers (gray boxes). Primary neuroblasts are 
marked with a star. (A-B) 48-hr MARCM clones in central brain neuroblasts. Two separate optical 
sections from a Z-stack through each clone are shown. Neuroblast clones are reported by GFP 
expression. (A, A’) Ase+ neuroblasts exclude Pros from the nucleus, and generate Ase+Pros+ GMCs 
(open arrowhead) and Ase-Pros+ neurons (closed arrowhead). (B, B’) PAN neuroblasts do not have 
nuclear Pros. All Ase- (open arrowhead) and many Ase+ (closed arrowhead) daughters do not have 
nuclear Pros. GMCs are Ase+Pros+ (closed arrow) and neurons are Ase-Pros+ (open arrow). (C-D) Many 
PAN neuroblast progeny express the neuroblast markers CycE (C) and Dpn (D). (E-H) Neuroblast 
daughter cells in mitosis (arrowheads). Mira is not present in mitotic GMCs (E’) but segregates 
asymmetrically in some progeny of the PAN neuroblast (F’). Similarly, Pros is cytoplasmic in mitotic 
GMCs (G’) but asymmetric cortical in some PAN progeny (H’). (I-J) 24-hr (I) and 48-hr (J) secondary 
neuroblast clones contain multiple Ase+ cells (I) and multiple neurons (J). Scale bars: 10µm. 
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To find out if the presumptive secondary neuroblasts divide asymmetrically, we analyzed the 
localization of several proteins known to regulate asymmetric divisions in embryonic and 
larval neuroblasts. Mitotic GMCs localize Insc to a cortical crescent but not Mira because 
Mira is degraded after GMC birth (Fig. 6E, E’, (Ikeshima-Kataoka et al., 1997; Matsuzaki et al., 
1998; Schuldt et al., 1998; Shen et al., 1997)). In the PAN lineages, some daughters maintain 
cortical Mira (Fig. S4B) and, like neuroblasts, localize Insc and Mira to opposing crescents in 
mitosis (Fig. 6F’). Similar observations were made for Pros, which is dispersed in the 
cytoplasm of mitotic GMCs, but forms a crescent in some mitotic progeny of the PAN lineage 
(Fig. 6G’, 6H’). Furthermore, Brat, Numb, and aPKC all show asymmetric localization in the 
presumptive secondary neuroblasts (Fig. S4C-E), and asymmetrically sized divisions occur in 
these cells as well (Fig. 5D, arrowhead). All of these observations strongly suggest that the 
Ase+ cells without nuclear Pros are indeed asymmetrically dividing secondary neuroblasts. 
 
If the secondary neuroblasts divide in a self-renewing manner, they should generate MARCM 
clones with greater than 4 neurons. We therefore searched for these clones in the posterior 
medial brain. Besides the PAN clones, many clones in this region consist of 1 or 2 Elav+ cells 
(data not shown), the clone type predicted by an origin in GMCs. It is also possible to observe 
clones in this region with multiple Ase+ cells (Fig. 6I) or clones with more than 4 Elav+ cells 
(Fig. 6J). Due to the low frequency of MARCM clone induction, it is unlikely that these multi-
cell clones are overlapping GMC clones. Instead, they probably arise from sequential, GMC-
producing divisions of the small neuroblast-like cells. Since some clones consist exclusively 
of multiple Elav+ cells, secondary neuroblasts may eventually divide terminally or die. These 
findings indicate that a PAN neuroblast divides asymmetrically to produce a secondary 
neuroblast. The secondary neuroblast is initially Ase-, but it eventually upregulates Ase and 
divides asymmetrically to self-renew and generate a GMC. 
 
To test whether such a lineage could produce the observed cell types in PAN clones, we 
made a computational model of the PAN lineage. The program tracked the numbers of the 
various cell types over time, starting with an initial division of the PAN neuroblast at time t = 
0. This was done by looping simple, partially-recursive population functions according to 
division rate and latency time parameters (see supplementary methods for additional details). 
Using the model, we were able to determine a limited range of time for each event in the 
proposed PAN neuroblast lineage that returned values in good agreement with the observed 
cell populations at 24 and 48 hours (Fig. 9). We conclude from this that the proposed lineage  
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Figure 7. Immature Ase- secondary neuroblasts enter mitosis in brat 
Immunostainings of MARCM clones reported by GFP expression and labeled with indicated markers 
(gray boxes). Stars indicate primary neuroblasts and circles indicate daughter cells. (A-C) Pros in 24-hr 
clones. In wild type PAN clones, Pros is nuclear in some daughters (A, arrowhead). In brat Ase+ 
clones, Pros is nuclear in all daughters (B), but in brat PAN clones, no daughters have nuclear Pros (C). 
(D, E) Mitotic Ase- cells in brat PAN clones. In 24-hr clones, Ase- secondary neuroblasts enter mitosis 
(D’). In 48-hr clones, mitotic Ase- cells increase in size and number (E). (F-G) brat secondary 
neuroblast clones. Differentiated Pros+ (F) Ase+ and Elav+ (G) cells are created in the absence of brat. 
(H-J) numb clones. In 24-hr numb Ase+ clones, all daughters have nuclear Pros (H). Pros is not nuclear 
in daughters of numb PAN neuroblasts (I). Ase- daughters enter mitosis in numb 48-hr PAN clones. 
Scale bars: 10µm. 
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can plausibly generate the numbers of secondary neuroblasts, GMCs, and neurons observed 
in PAN clones. 
 
4.3.4. brat secondary neuroblasts fail to progress beyond the immature Ase- state 
To investigate the initial events leading to overgrowth in brat PAN lineages, we analyzed 24-
hr brat MARCM clones. brat clones in Ase+ neuroblast lineages do not overgrow (Fig. 7B, 
Table 1C), confirming that these lineages are unaffected by loss of Brat. Surprisingly, brat 
clones in PAN lineages show an undergrowth phenotype at 24 hours – they contain about 
half the number of progeny as wild type clones (Fig. 7C, Table 1C). We determined the 
identity of the brat daughters by staining with anti-Pros. In wild type PAN clones, some cells 
import Pros into the nucleus (Fig. 7A, Table 1B), showing that after 24 hours secondary 
neuroblasts divide and give rise to Pros+ GMCs and neurons. In brat PAN clones, no progeny 
have nuclear Pros, suggesting all are secondary neuroblasts (Fig. 7C). While other groups 
report similar findings on the absence of nuclear Pros in brat (Bello et al., 2006; Lee et al., 
2006c), we use Pros staining simply to discriminate neuroblasts from more differentiated 
cells. If the brat secondary neuroblasts entered mitosis, we would expect to see far more than 
the 10 progeny produced in 24 hr-clones. This implies a cell cycle block in brat secondary 
neuroblasts. In agreement with this, previous work shows that brat neuroblasts generate 
progeny that are cell cycle delayed (Lee et al., 2006c).  
 
To investigate the nature of the cell cycle block, we checked the expression of cell cycle 
markers in the larval brain. Mitotic central brain neuroblasts express the G1-S transition 
markers CycE and E2F1, and these proteins associate with segregating DNA in late telophase 
(Fig. S5A-B). This should cause the larval neuroblast and its daughter to enter S phase shortly 
after cytokinesis, similar to embryonic neuroblasts (Weigmann and Lehner, 1995). To analyze 
the kinetics of this in greater detail, we stained clones containing telophase PAN neuroblasts 
with anti-E2F1, which does not label S-phase cells, and with anti-CyclinA (CycA), a marker 
for S and G2 phases (Reis and Edgar, 2004). In wild-type clones, the E2F1-positive daughter 
being born is located near other daughters with low or undetectable levels of E2F1 (Fig. S5C). 
Since the PAN neuroblast always directs the birth of its daughter towards a group of Ase- 
secondary neuroblasts (Fig. S3, n=7 telophase PAN neuroblasts), it is likely that the daughters 
with low E2F1 are both Ase- and recently born. The low E2F1 indicates a rapid entry into S 
phase by the Ase- secondary neuroblast shortly after its birth. This is followed by 
accumulation of CycA and re-expression of E2F1, indicating progression to G2 (Fig. S5C and 
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S5C’). Importantly, we observe the same events in brat secondary neuroblasts, so they must 
also progress through S phase (Fig. S5D). Therefore, we conclude that the cell cycle delay in 
brat secondary neuroblasts occurs in G2. Since the number of progeny in the 24-hr brat clone 
is small (Table 1C), the block could be maintained for around 24 hours. 
 
In order to find out why the cell cycle is blocked in brat secondary neuroblasts, we analyzed 
other regulators of cell proliferation. The pro-growth and proliferation protein dMyc is present 
in both wild-type and brat secondary neuroblasts (Fig. S6), indicating the delay is not due to 
lack of growth stimulus. The Cdk inhibitor Dacapo (Dap) could potentially slow the cell 
cycle, but we did not detect Dap in brat secondary neuroblasts (data not shown). To test 
whether the delay is caused by a defect in the differentiation of secondary neuroblasts, we 
checked the expression of Ase. In wild type PAN clones, Ase is upregulated some time after 
daughter cell birth (Fig. 5C). In brat mutant PAN clones, upregulation of Ase never occurs 
(Fig. 7D). This suggests that the brat mutant secondary neuroblasts have not fully matured. 
Collectively, these observations show that loss of Brat does not impede secondary neuroblast 
entry into S phase, but it does prevent upregulation of Ase. This triggers a G2 block in the 
Ase- secondary neuroblast. 
 
4.3.5. Immature Ase- secondary neuroblasts enter mitosis in brat 
A terminal cell cycle delay in an immature secondary neuroblast would not produce 
overgrowth in brat. Therefore, we checked whether the Ase- secondary neuroblasts ever 
entered mitosis in brat clones. In wild type PAN lineages, Ase- secondary neuroblasts are 
never positive for phospho-histone H3 (Fig. 5D, 5D’, and data not shown). In 24-hr clones in 
brat PAN lineages, we occasionally observe Ase- secondary neuroblasts in mitosis (Fig. 7D’). 
Although all cells in the clone are Ase-, it is possible to distinguish secondary neuroblasts 
from PAN neuroblasts by size: the PAN neuroblast has a cell diameter greater than 10 µm, 
while secondary neuroblasts have a diameter of around 5-7 µm. Mitosis in an immature 
secondary neuroblast with a deregulated cell cycle may be the event that initiates brat mutant 
overgrowth. By the 48-hr time point, mitotic Ase- cells have increased in size and number 
(Fig. 7E). Most cells in the brat clone remain Ase-, showing that the daughters of the mitotic 
Ase- cells also fail to upregulate Ase and differentiate. 
 
Could the mitotic immature secondary neuroblast be solely responsible for the brat 
overgrowth? The brat PAN neuroblast cannot generate the bulk of the cells, since it produces 
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only 10 cells in 24 hours (Table 1C) and the 48-hr brat clone contains over 100 cells (124 ± 
14 cells, n=5 clones). If brat mutant Ase+ secondary neuroblasts or GMCs cause overgrowth, 
we should be unable to detect MARCM clones with more than 1 neuron. However, we 
regularly observe brat clones containing multiple Elav+, Pros+, and Ase+ cells in the medial 
central brain (Fig. 7F, 7G). This leaves the Ase- secondary neuroblast as the likely origin of 
the overgrowth. We conclude from these observations that the earliest events in brat 
overgrowth are failure to achieve Ase+ secondary neuroblast status and cell cycle block in 
G2. Escape from the block and completion of mitosis in the immature Ase- secondary 
neuroblast establishes a lineage that is unable to produce differentiated daughter cells (Fig. 
7E). We propose that these events are the source of the overgrowing neuroblasts characteristic 
of brat mutant brains.  
 
4.3.6. Notch signaling regulates secondary neuroblasts in PAN lineages 
We have shown that loss of Brat causes defective differentiation in transit-amplifying 
secondary neuroblasts and this leads to overgrowth. It is therefore critical to understand how 
this transit-amplifying lineage is specified and regulated. In some mammalian transit-
amplifying stem cells lineages, Notch controls proliferation and differentiation (Wilson and 
Radtke, 2006). Furthermore, in Drosophila larval brains, mutation in numb, an antagonist of 
Notch, causes overgrowth and production of ectopic neuroblasts (Lee et al., 2006a; Wang et 
al., 2006). To test whether misregulation of Notch signaling causes defects in the transit-
amplifying PAN lineages, we generated numb MARCM clones. In Ase+ neuroblast lineages, 
numb loss of function does not affect production of differentiated GMCs and neurons (Fig. 7H 
and S7A). By contrast, numb mutant 24-hr PAN clones contain secondary neuroblasts 
delayed in G2 (Fig. 7I, Table 1C, and Fig. S5E). This phenotype is identical to that caused by 
loss of Brat. Similarly, 48-hr PAN clones mutant for numb are filled with undifferentiated Ase- 
cells (Fig. 7J, Fig. S7B). This indicates that Numb is required to promote the maturation of 
Ase- secondary neuroblasts, perhaps by downregulating Notch signaling. To check whether 
ectopic activation of Notch generally causes overgrowth of the PAN lineage, we expressed 
the Notch intracellular domain (Nintra) in all neuroblasts using insc-Gal4. Because it is lethal at 
embryonic stages, we restricted Nintra expression to the larval stages using Gal80ts. Consistent 
with previous results (Wang et al., 2006), we observed that upon Nintra overexpression, the 
brain becomes filled with PAN neuroblasts (Fig. S7D). A similar phenotype is observed when 
Notch is hyperactivated through loss of function of lgd (Fig. S7E), a gene required for protein 
trafficking of the Notch receptor and downregulation of Notch signaling (Gallagher and 
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Knoblich, 2006; Jaekel and Klein, 2006). These results show that overactivation of Notch 
leads to the production of ectopic PAN neuroblasts, probably by interfering with 
differentiation in the PAN lineages. 
 
Since Notch overactivation results in ectopic PAN neuroblasts, we tested whether Notch loss 
of function would result in too few PAN neuroblasts. For this, we used insc-Gal4, Gal80ts, and 
transgenic Notch RNAi to deplete Notch in all neuroblasts (Fig. S8). Knockdown of Notch has 
two different effects on PAN lineages: it either eliminates them entirely or reduces the number 
of associated Ase+ progeny (Fig. S7G). Similarly, we observe complete absence of PAN 
lineages when Notch signaling is inhibited by expressing Numb in all neuroblasts (Fig. S7H). 
We conclude from these results that Notch signaling must be active in the PAN neuroblast 
and the secondary neuroblasts to produce a wild type lineage, but overactivation of Notch 
causes uncontrolled division of Ase- secondary neuroblasts.  
 
4.3.7. Prospero acts after Brat and Numb in the PAN lineage 
Since loss of Brat or Numb causes defects only in PAN lineages, we investigated whether this 
is also true for the cell fate determinant Pros. The absence of nuclear Pros in brat clones has 
led to a model where Brat exerts its effects on cell fate by regulating Pros (Bello et al., 2006; 
Lee et al., 2006c). If this is true, then loss of Brat and loss of Pros should have comparable 
consequences. We tested this by generating pros MARCM clones. In Ase+ lineages, pros 
clones fail to produce significant numbers of Elav+ neurons in 77% of clones examined (n=26 
Ase+ clones; Fig. 8A, 8B), a phenotype distinct from brat or numb. In the PAN lineages, loss 
of Pros results in production of many Ase+ progeny but almost no Elav+ cells (Fig. 8C, 8D). 
These results confirm that Pros is required to make differentiated neurons (Bello et al., 2006; 
Betschinger et al., 2006; Choksi et al., 2006; Lee et al., 2006c). The presence of Ase+ progeny 
in the pros mutant PAN lineage indicates a requirement for Pros only after the transition from 
Ase- to Ase+ secondary neuroblast status. We conclude that Pros acts at a later time point in 
the PAN lineage than Brat. Consistent with this, pros-Gal4 is not detectably expressed in PAN 
neuroblasts or Ase- secondary neuroblasts, and it becomes visible only in Ase+ secondary 
neuroblasts (Fig. 8E, 8F). We cannot exclude that pros transcription in the PAN neuroblasts 
and Ase- secondary neuroblasts requires a promoter not contained in pros-Gal4. Still, since 
loss of Brat and loss of Pros cause fate misspecification in different cell types, these results 
demonstrate that Brat does not act exclusively by regulating Pros. 
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Figure 8. Pros is not required for maturation of secondary neuroblasts 
Immunostainings labeled with indicated markers (gray boxes). (A-D) pros MARCM clones reported by 
GFP expression. Stars indicate primary neuroblasts. Two separate optical sections from a Z-stack 
through each clone are shown. Loss of Pros in Ase+ lineages results in failure to generate neurons (A, 
B). In PAN lineages, Pros is not required to generate Ase+ daughters, but neurons fail to differentiate (C, 
D). (E-F) pros-Gal4 expression reported by GFP. pros-Gal4 is not expressed in the PAN neuroblasts (E) 
or their Ase- daughters (circles, F). (G-J) PAN lineage behavior in other tumor models. Early third instar 
larval brains. Insets: Ase+ neuroblasts of the ventral nerve cord. Expression of membrane-targeted  
aPKC (H) or loss of AurA (I) results in overgrowth in both Ase+ and PAN lineages, but loss of Lgl affects 
PAN lineages more strongly (J). Scale bars: (A-D, F) 10 µm; (E, G-J) 50 µm. 
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The different sensitivities of Ase+ and PAN neuroblasts to loss of cell fate determinants 
prompted us to analyze whether brain overgrowth caused by other genetic lesions begin in 
PAN lineages. Overexpression of membrane-targeted aPKC (aPKCCAAX) (Lee et al., 2006b)) and 
loss of the mitotic kinase aurora-A (AurA) (Lee et al., 2006a; Wang et al., 2006) cause 
overgrowth in both Ase+ and PAN lineages (Fig. 8I, 8J), but loss of lgl (Betschinger et al., 
2006) affects PAN lineages much more strongly than Ase+ lineages (Fig. 8K). This may be 
because aPKCCAAX and aurA affect the function of proteins that promote the differentiation of 
GMCs and secondary neuroblasts, while lgl misregulates proteins required for differentiation 
of secondary neuroblasts more severely. We conclude that while PAN lineages contribute to 
a general neuroblast overgrowth phenotype in the aPKCCAAX and aurA brains, they are 
primarily responsible for the overgrowth in lgl mutants. 
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4.4. DISCUSSION 
It was previously thought that all daughters of Drosophila neuroblasts are GMCs. We show 
that several neuroblasts in the Drosophila larval brain repress Ase and produce daughters that 
behave like secondary neuroblasts. The proteins Brat and Numb act to promote the 
progression of recently born secondary neuroblasts from an Ase- to an Ase+ status. Once the 
secondary neuroblast becomes Ase+, it begins to divide and produce GMCs. In the absence of 
Brat or Numb, the transition from Ase- to Ase+ secondary neuroblast fails to occur, and the 
Ase- secondary neuroblast enters mitosis. This incorrectly specified mutant daughter cell is 
unable to make differentiated progeny, and it initiates overgrowth of neuroblast-like cells in 
the larval brain.  
 
4.4.1. Ase and transit-amplifying neuroblast lineages 
Ase is best known for its role as a neural precursor gene, so its absence from any neuroblast is 
surprising. Three mechanisms are known to downregulate expression of Ase. One is 
transcriptional repression mediated by Pros (Choksi et al., 2006). Since Pros is not nuclear in 
neuroblast nuclei, it is unlikely to repress ase in the PAN neuroblasts. The transcription factor 
Tramtrack (Ttk) also represses ase transcription (Badenhorst et al., 2002), and we analyzed the 
reporter line ttk0219 to see if ttk expression correlated with the PAN lineage. Although the ttk 
reporter is active in some PAN neuroblasts, it is also active in many Ase+ neuroblasts, 
suggesting that ttk transcription is not sufficient for specifying PAN identity (data not shown). 
Finally, Notch signaling can indirectly repress Ase by downregulating expression of two ase 
activators, the transcription factors Achaete and Scute (Oellers et al., 1994; Heitzler et al., 
1996). We favor the idea that Notch signaling mediates Ase repression because inhibiting 
signaling results in elimination of PAN neuroblast lineages (Fig. S7G, S7H). Since all central 
brain neuroblasts appear to express equal levels of Notch receptor (Fig. S8) and report equal 
levels of signaling through the reporter construct gbe+Su(H) lacZ (data not shown, (Almeida 
and Bray, 2005)), other factors must undetectably enhance Notch signaling levels  in the PAN 
neuroblast or otherwise act together with Notch to specify PAN identity. 
 
It is unclear why PAN neuroblasts downregulate Ase because there are few known Ase target 
genes. The three neural precursor cell types known to generate neuroblasts – the embryonic 
neuroepithelium (Jarman et al., 1993), the optic lobe neuroepithelium (Egger et al., 2007), 
and now the PAN neuroblast – do not express Ase, although the PAN neuroblast is unique in 
this group for expressing most other neuroblast markers. In the optic lobe, Ase expression is 
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correlated with upregulation of Dap and cell cycle exit (Wallace et al., 2000). This probably 
does not play a role in the central brain since most of the cycling neuroblasts are Ase+. 
Ectopic expression of Ase in imaginal discs upregulates achaete and the E3 ubiquitin ligase 
neuralized (Brand et al., 1993), but at first glance, neither of these gene products seem like 
they would conflict with secondary neuroblast fate. Still, Ase expression is clearly not 
compatible with the production of transit-amplifying lineages because ectopic Ase abolishes 
them (Fig. 4B, 4B’). To test whether the inverse is true and downregulating Ase generates 
supernumerary transit-amplifying neuroblast lineages, we analyzed ase1 mutants. Ase protein 
was gone but additional neuroblasts producing daughters without nuclear Pros were not 
observed (data not shown). We interpret these results to mean that downregulation of Ase is 
not an instructive signal for specification of PAN neuroblast identity, but rather a 
consequence of specification. While failure to express Ase in the secondary neuroblasts might 
be predicted to lead to overgrowth, as in numb or brat, we could detect no overgrowth in the 
ase mutant brains. This implies that once the PAN neuroblast daughter is born, Ase is not 
required to promote the transition from immature to mature secondary neuroblast. 
Nevertheless, Ase expression is a useful reporter of this cell fate transition. 
 
4.4.2. Numb, Brat, Pros, and transformation of progenitor cells 
In the PAN lineage, the most recently born daughter cells are Ase- secondary neuroblasts. 
This immature state is normally quickly bypassed when the cell becomes an Ase+ secondary 
neuroblast (Fig. 9). Our data indicate that Brat and Numb promote this transition, because in 
the absence of either protein, the progeny of the PAN neuroblast fail to become Ase+. Numb 
inhibits Notch signaling, so this phenotype shows that downregulation of Notch allows the 
secondary neuroblast to mature and become Ase+. Since loss of Brat and loss of Numb have 
identical phenotypes in 24-hr clones, does this mean that Brat is also an antagonist of Notch? 
Two points argue against this hypothesis. First, although Brat is expressed in the Drosophila 
sensory organ precursor and segregates asymmetrically (Betschinger et al., 2006), its loss does 
not cause any change in daughter cell identity (A. Hutterer and J.A.K., unpublished results). 
This system is sensitive to levels of Notch signaling, so the result is inconsistent with a role for 
Brat in the regulation of Notch. Second, unlike overexpression of Numb, overexpression of 
Brat can not silence reporting through the Notch sensor gbe+Su(H) lacZ in the larval brain 
(data not shown). Thus, Brat does not seem to regulate cell fate by acting through Notch. 
While we cannot exclude that Brat regulates Notch signaling in a Su(H)-independent manner, 
the exact molecular function of Brat in this context remains to be discovered. 
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Figure 9. Models of neuroblast lineages in the central brain 
(A-C) Lineage diagrams with estimated time for each stage and cartoons of corresponding neuroblast 
clones. (A) Self-renewing Ase+ neuroblasts produce progeny that follow the standard GMC-neuron 
progression. (B) PAN neuroblasts generate Ase- secondary neuroblasts that mature into self-renewing 
Ase+ secondary neuroblasts. These transit-amplifying cells produce GMCs, which divide terminally to 
produce two neurons. (C) In the absence of Brat, Ase- secondary neuroblasts are unable to become 
Ase+. Upon mitotic entry, they become tumor-initiating cells. (D-E) Plots showing production of 
neuroblast progeny over time. Production of neurons in Ase+ lineages is linear (D), while production of 
neurons in PAN lineages is exponential (E). Plots were created using Matlab and computer-modeled 
neuroblast lineages (see supplemental methods for details). Colored circles correspond the cell 
numbers recorded in Table 1B. 
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Loss of Brat and Numb may cause identical phenotypes in the PAN lineage not because they 
have identical functions, but because of the nature of the Ase- secondary neuroblast. In the 
Ase+ neuroblast lineage, Pros is imported into the nucleus of the neuroblast daughter. One 
cell fate determinant in addition to Pros is enough to establish GMC fate, because loss of Brat 
or Numb alone does not prevent neural differentiation (Fig. 4G, 4I, 7B, 7H, S7A). In the PAN 
lineage, the Ase- secondary neuroblast does not have nuclear Pros, so it uses only Brat and 
Numb to make it different from its mother. For this reason it may be more sensitive to loss of 
either cell fate determinant. Additionally, besides small size and increased levels of Brat and 
Numb inherited at the time of its birth, we did not find a single molecular marker that makes 
the Ase- secondary neuroblasts different from PAN neuroblasts. This suggests the Ase- 
secondary neuroblast may not yet be strongly committed to its fate. While this unstable state 
is normally bypassed when the cell becomes an Ase+ secondary neuroblast, in the absence of 
Brat or Numb, the weak commitment of the Ase- secondary neuroblast may ensure that no 
matter which protein is lost, the result will be identical: it reverts to a fate similar to its 
mother’s. Instead of becoming a transient-amplifying progenitor, the Ase- secondary 
neuroblast commits to unlimited self-renewal. Because this occurs in a cell that may not 
express Pros (Fig. 8F), mitosis therefore begins the production of cells unable to differentiate 
(Fig. 9). This could explain why brat neuroblasts do not appear to express Pros or segregate it 
asymmetrically (Bello et al., 2006; Betschinger et al., 2006), and could also explain why 
expressing Pros rescues brat tumors. The defect in the lineage caused by brat – mitosis in cells 
not expressing Pros – is now repaired. We propose that blocking full commitment to the 
intermediate progenitor fate and allowing mitosis in a mis-specified daughter may be a 
general mechanism for causing overgrowth in a transit-amplifying lineage. While transit-
amplifying lineages offer the possibility to produce differentiated cells at a faster rate than 
stem cell lineages without intermediate progenitors (Fig. 9D, 9E), this may always come with 
a higher risk of tumorigenesis. Our data suggest that specification of secondary neuroblast fate 
is a genetic weak point. 
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4.5. EXPERIMENTAL PROCEDURES 
Fly Strains 
Fly strains used were 1407-Gal4 inserted in the insc promoter (Betschinger et al., 2006); UAS 
ase (Brand et al., 1993); UAS brat RNAi (Dietzl et al., 2007); ase-Gal4 (Zhu et al., 2006); 
FRT40A, brat192 (Betschinger et al., 2006); FRT40A, brat150 (Betschinger et al., 2006); FRT40A, 
numb15 (Berdnik et al., 2002; Bhalerao et al., 2005); FRT82B, pros17 (Doe et al., 1991); UAS 
CD8::GFP (Bloomington stock center); MARCM stocks using C155-Gal4 (Lee et al., 1999); 
pros-Gal4 (a gift from F. Matsuzaki); FRT40A, lgl1 and FRT40A, lgl4 (from F. Matsuzaki); 
FRT82B, aurA87Ac-3 and FRT82B, aurA37 (Berdnik and Knoblich, 2002); UAS aPKCCAAXWT 
(Sotillos et al., 2004). To prevent embryonic lethality some UAS constructs were expressed 
with 1407-Gal4 and Gal80ts (Bloomington stock center 7018) and reared at 18 degrees until 
larval stages. Then larvae were incubated at 29 degrees for 3 days to allow expression of the 
transgene. All other transgenes were expressed at 25 degrees. 
 
Antibodies 
Antibodies used were guinea pig anti-Ase (affinity purified, 1:100, (Bhalerao et al., 2005)), 
mouse anti-Elav (1:100, Developmental Studies Hybridoma Bank, University of Iowa 
[DSHB]), rat anti-Elav (1:300, DSHB), mouse anti-Pros (1:10, DSHB), guinea pig anti-Dpn 
(1:1000, gift from J. Skeath), mouse anti-CycE (1:100, H. Richardson), rabbit anti-Mira (1:100, 
(Betschinger et al., 2006)), rabbit anti-phospho histone H3 (1:1000, Upstate), mouse anti-Insc 
(1:100, (Schaefer et al., 2001)). 
 
Immunohistochemistry 
To generate MARCM clones, larvae were heat shocked in Eppendorf tubes for 90 min at 37 
degrees, then allowed to recover for 24 or 48 hours on fly food at 25 degrees. Other 
genotypes were dissected as wandering third instar larvae unless otherwise noted. Larval 
brains were dissected in PBS, fixed in 5% paraformaldehyde in PBS for 20 minutes, and 
blocked using 2% normal donkey serum in PBS with 0.05% Triton-X-100. Brains were 
incubated with primary antibody overnight and labeled using standard methods, then 
mounted in Vectashield or (Vector Laboratories). To visualize cortical actin, we used 
rhodamine Phalloidin (Molecular Probes) or Alexa 488 Phalloidin (Molecular Probes). 
Secondary antibodies were conjugated to Alexa 405, Alexa 488, Alexa 568 (all from 
Molecular Probes) or Cy5 (Jackson Immunofluorescence). Images were recorded on a Zeiss 
LSM510 confocal microscope. 
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4.6. SUPPLEMENTARY DATA 
Supplementary figures 
 
 
 
Figure S1. 8 neuroblasts per brain lobe are Ase- 
Immunostainings of a third instar brain. Two Z-sections from a Z-stack are shown. (A) GFP reporting 
ase-Gal4 expression (green) stained for Ase (red) and Phalloidin (blue). Medial Ase- neuroblasts with 
surface-level progeny are indicated with a star, Ase- neuroblasts with progeny located in interior brain 
regions are indicated with a circle. Note that ase-Gal4 is not expressed in the Ase+ progeny of the Ase- 
neuroblasts. (A’) The same brain, with Ase (red) and Phalloidin (green) only. 
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Figure S2. Reduction of Brat protein by knockdown with transgenic RNAi 
(A-E) Third instar brains with GFP reporting Gal4 expression (green) stained for Brat (red). Brat staining 
is also shown alone (gray). (A-C) insc-Gal4 is expressed in all neuroblasts. Brat protein is present in 
control brains (A, A’) but depleted with Brat RNAi alone (B, B’) or Brat RNAi plus UAS ase (C, C’). (D-
E) ase-Gal4 is expressed in Ase+ neuroblasts. Brat protein is present in control brains (D, D’) but 
depleted in the Ase+ neuroblasts where Brat RNAi is expressed (E, E’). 
 
 
 
43 
 
 
 
 
Figure S3. Characteristics of Ase- secondary neuroblasts 
(A) Above: 48-hr MARCM clone reported by GFP (green) with staining of Ase (red) and phospho-
histone H3 (blue). The Ase- daughter being born (open arrowhead) from the telophase PAN neuroblast 
(star, outline) is situated near another Ase- daughter (closed arrowhead). Below: higher magnification. 
(B) 48-hr MARCM clone reported by GFP (green) with staining of Ase (red in B) and CycE (red in B’). 
An Ase- secondary neuroblast is positive for CycE (arrowhead). 
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Figure S4. Asymmetric protein localization in secondary neuroblasts. 
(A-B) 48-hr MARCM clones reported by GFP (green) with staining of Mira (green in A and B white in 
A’ and B’). Star indicates primary neuroblasts. In Ase+ lineages, few progeny retain cortical Mira (A), 
but many daughters of PAN neuroblasts do (B). (C-F) PAN lineages (lavender dotted line) identified by 
absence of ase-Gal4 expression and mitotic secondary neuroblasts (arrowhead and white dotted line) 
identified by segregation of Pros (green). Star indicates approximate position of the primary neuroblast, 
which is below the plane shown in E and F. Secondary neuroblasts asymmetrically segregate aPKC (red 
in C, arrowhead), Numb (red, D), Brat (red, E), and Mira (red, F). 
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Figure S5. Cell cycle delay in brat secondary neuroblasts occurs in G2 
(A-B) wild type central brain neuroblasts stained with phalloidin (green), CycE (red) and p-H3 (blue). 
The expression of CycE in mitotic neuroblasts is clearly visible before nuclear envelope breakdown (A). 
In PAN neuroblasts, CycE associates with DNA in late telophase (B, arrowheads). It is also expressed in 
mitotic secondary neuroblasts (B, arrow). (C-E) Cell cycle profiling in 24-hr MARCM clones with 
telophase PAN neuroblasts. The clone is reported by expression of GFP (green). Stars indicate primary 
neuroblasts, and circles indicate progeny. The daughter being born is unmarked, but has a distinctive 
ring of GFP around the nucleus. In wild-type clones (C) and in brat clones (D), E2F1 is present in the 
cells being born but not in the nearest neighbors of the newly born daughter. Cyclin A is absent from 
the dividing cells but upregulated in the daughters near the site of birth (C’, D’). In numb clones, CycE 
associates with DNA in the daughter being born, but it is absent from the newest daughter’s neighbors 
(E, E’).  
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Figure S6. dMyc is expressed in the progeny of control and brat PAN neuroblasts 
(A-B) 24-hr MARCM clones reported by GFP (green) with staining of dMyc (red). Neuroblasts are 
indicated with a star and progeny are indicated with a circle. Both wild type (A) and brat (B) 
neuroblasts produce daughter cells that express dMyc.  
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Figure S7. Notch signaling regulates the PAN lineage 
(A-B) 48-hr numb MARCM clones reported by GFP (green) stained for Ase (red) and Elav (blue). Loss of 
numb does not affect differentiation in Ase+ neuroblasts (A, A’). In PAN neuroblasts, loss of numb 
results in overgrowth of Ase- progeny (B). (C-E) Third instar brains stained for Ase (red), Elav (blue), and 
Phalloidin (green). Control brains (C) have a small number of PAN neuroblasts. Overactivating Notch 
by expressing Notch intracellular domain (Nintra, D) or removing lgd (E) generates ectopic PAN 
neuroblasts. (F-H) Medial neuroblast lineages (outline) stained for Ase (red) and Phalloidin (green). 
Control brains have PAN neuroblasts with many Ase+ progeny (F). Notch knockdown eliminates PAN 
neuroblasts or reduces the number of Ase+ progeny (G). Inhibiting Notch by overexpressing Numb 
eliminates PAN lineages (H). Scale bars: (A-B) 10 µm; (C-H) 40µm. 
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Figure S8. Reduction of Notch protein by knockdown with transgenic RNAi 
(A-B) Third instar brains with staining of Phalloidin (red) and Notch extracellular domain (Nextra, 
green). Nextra staining is also shown alone (gray). In control brains, Nextra is present on the cell suface 
of neuroblasts and some of their progeny (A). In brains expressing Notch RNAi under the control of 
insc-Gal4, Notch protein is depleted (B). 
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Fly strains and antibodies 
Additional fly strains used were: UAS Nintra (a gift from S. Bray); UAS notch RNAi (Dietzl et al., 
2007); UAS numb (Chien et al., 1998); lgdd10 (Gallagher and Knoblich, 2006; Jaekel and 
Klein, 2006); gbe+Su(H) lacZ (Furriols and Bray, 2001); ttk0219 (Lai et al., 1996); ase1 
(Dominguez and Campuzano, 1993). 
Additional antibodies used were: mouse anti-dMyc (1:5, B. Edgar); mouse anti-Nextra (1:200, 
DSHB); rabbit anti-Brat (1:100, (Betschinger et al., 2006)); rabbit anti-PKCz/aPKC (1:200, 
Santa Cruz); rabbit anti-Numb (1:200); guinea pig anti-dE2F1 (1:1000, T. Orr-Weaver); rabbit 
anti-CyclinA (1:1000, D. Glover). 
 
Computer modeling of neuroblast lineages 
We propose that the PAN neuroblast produces an Ase- intermediate progenitor. This Ase- cell 
becomes Ase+ before dividing to make a GMC, and the GMC will divide terminally to 
produce two neurons. Such a lineage is not conducive to modeling as analytical expressions 
because of the recursive nature of the cell populations, the varying cell identities within a 
single cell cycle, and the treatment of divisions as discrete events in time.  Instead, we used 
computer routines to determine if the proposed lineage could theoretically produce the 
numbers of cell types observed in 24- and 48-hr clones, and what cell division rates and 
latency periods would be required to produce those numbers. We developed three versions 
of the routines using the Matlab v7 software package (Mathworks Inc., New York, NY). Code 
is available upon request. The results of this analysis are presented in Fig. 9. 
 
The first routine is a simulation of the Ase+ neuroblast lineage, which we used to validate our 
computational approach.  In this lineage, the Ase+ neuroblast produces a GMC, and the GMC 
divides terminally to produce two neurons. Input parameters for this model are: 
Rnb, the rate of neuroblast division 
Rgmc, the time between creation and division of the GMC 
Rnb and Rgmc are determined empirically from the clonal analysis in Table 1B. Each GMC 
and each pair of neurons is assumed to represent one neuroblast division. Therefore, Rnb = t / 
(GMC + neurons/2), where t = time elapsed since clone induction. Rgmc is calculated to be 
GMC  Rnb. Total number of GMCs (Ngmc) at a given time sample was determined as the 
sum of Ngmc at the previous time sample, plus the number of new GMCs (i.e. number of 
neuroblast divisions) created since the previous sample, minus the number of GMCs that 
divided to create neurons.  The number of neurons at a given time sample was calculated as 
the number at the previous sample plus twice the number of GMCs that divided since the 
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previous sample. Our empirically determined Rnb and Rgmc, when used as inputs in this 
routine, produced total numbers of GMCs and neurons in close agreement with the observed 
numbers in 24- and 48-hr Ase+ neuroblast clones (see below). This provided proof of concept 
for similar modeling of the more complicated PAN lineage.   
 
Our second routine simulated a model of the PAN lineage. In this routine, we assumed that 
the secondary neuroblasts have unlimited cell divisions. Input parameters for this model are: 
Rnb (see above),  
Lsnb-, a latency period between the creation of the Ase- secondary neuroblast and when it 
becomes Ase+, 
Lsnb+, a second latency period between when the secondary neuroblast becomes Ase+ and 
the first division of the secondary neuroblast,  
Rsnb, the rate of secondary neuroblast division  
Rgmc (see above).   
We assumed that Rnb and Rgmc are identical for Ase+ and PAN neuroblast lineages, and 
varied Lsnb-, Lsnb+, and Rsnb until we reached output in good agreement with the observed 
numbers of secondary neuroblasts, GMCs, and neurons in PAN clones. An important 
limitation placed on the values of Lsnb, Lsnb+, and Rsnb was the observation that it takes 
about 24 hours to create two neurons (see Table 1B); therefore Rnb + Lsnb + Lsnb+ + Rsnb + 
Rgmc must be less than 24 hours. A new Ase- secondary neuroblast (snb-) was created every 
Rnb hours. The total number of Ase- secondary neuroblasts (Nsnb-) at a given time sample is 
the sum of Nsnb- at the previous time sample, plus the number of new snb-, minus the 
number of snb- that start expressing Ase after latency period Lsnb-. The total number of Ase+ 
secondary neuroblasts (Nsnb+) at a given time sample is the sum of Nsbn+ at the previous 
time sample, plus the number of snb- starting to express Ase.  The number of GMCs (Ngmc) is 
the sum of the previous Ngmc, plus the number of new GMCs, minus the number of GMCs 
that divided to create neurons. The number of new GMCs is created from either snb+ just 
finishing the latency period Lsnb+, or snb+ that last divided Rsnb+ hours before. The total 
number of neurons (Nn) is the sum of the previous Nn, plus twice the number of GMCs that 
divided since the previous sample. 
 
The third routine simulated a model of the PAN lineage similar to the previous model, but 
with the Ase+ secondary neuroblast 'dying' after a specified number of divisons (Xsnb+). The 
total number of Ase+ secondary neuroblasts (Nase+) at a given time sample is subsequently 
calculated as the sum of the previous Nase+, plus the number of snb- starting to express Ase, 
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minus the number of snb+ older than Xsnb+  Rsnb+ hours. Limiting the Ase+ secondary 
neuroblasts to either 4 or 5 divisions could produce outputs in agreement with the observed 
numbers of progeny in PAN clones. 
 
Values used to generate the plots in Figure 9: 
Input, Ase+ neuroblast lineage, first routine: 
Rnb= 1.5 hours 
Rgmc = 8.5 hours 
 
Input, PAN neuroblast lineage, third routine: 
Rnb = 1.5 hours 
Lsnb- = 3.5 hours 
Lsnb+ = 1 hour 
Rsnb = 8.1 hours 
Rgmc = 8.5 hours 
Xsnb+ = 5 divisions 
 
 
 
 
52 
5. CHAPTER II – CHARACTERIZATION OF BARRICADE, A NOVEL 
REGULATOR OF LARVAL NEUROBLAST LINEAGES 
5.1. INTRODUCTION 
The identification and characterization of PAN lineages described in chapter I has been 
confirmed by two other studies that were published concomitantly to ours (Bello et al., 2008; 
Boone and Doe, 2008). Each study originally used different terms to describe same cell types 
and for sake of clarity a common nomenclature has been adopted. In this chapter, we are 
using the common terminology and changes are summarized below: 
Bowman and al. 2008 Common nomenclature 
Ase+ lineage Type 1 lineage 
PAN lineage Type 2 lineage 
Primary neuroblast (in PAN lineage) Neuroblast 
Secondary neuroblast (in PAN lineage) Intermediate Neural Progenitor (INP) 
 
Since this chapter strongly focuses on type 2 lineages, the next few paragraphs briefly 
summarize current knowledge about type 1 and type 2 lineages. 
 
5.1.1. Type 1 and type 2 neuroblast lineages 
Type 1 neuroblasts are the most common population of neuroblasts in the CB and they form 
relatively simple lineages (Fig. 10A&B). These neuroblasts express the cortical protein Mira 
and the nuclear transcription factors Ase and Dpn (Boone and Doe, 2008; Bowman et al., 
2008). Upon division they segregate Mira, Brat, Numb and Pros into the smaller GMC (Fig. 
10D) (Bowman et al., 2008; Boone and Doe, 2008; Bello et al., 2008). In the GMC, Mira and 
Dpn are degraded while Pros enters the nucleus and together with Brat and Numb, triggers 
differentiation. Each GMC divides symmetrically into two neurons. 
 
Type 2 neuroblasts are rare – eight per lobe – and are located on the posterior side of the 
brain (Fig. 10A) (Bowman et al., 2008). However, these lineages are highly relevant for two 
main reasons. Firstly, they form complex and long lineages that produce about one quarter of 
all neurons of the brain (Fig. 10C) (Bello et al., 2008; Izergina et al., 2009). Secondly, they are 
more prone to overproliferation and tumor formation (Bowman et al., 2008; Weng et al., 
2010; Neumuller et al., 2011). Type 2 neuroblasts can be distinguished from type 1 
neuroblasts by the fact that they express Dpn but lack Ase (Bowman et al., 2008; Boone and 
Doe, 2008). They divide asymmetrically into another neuroblast and an INP, which inherits 
Mira, Brat and Numb, but not Pros which is not expressed in type 2 neuroblasts (Fig. 10E) 
(Bowman et al., 2008; Boone and Doe, 2008; Bello et al., 2008). INPs are transit-amplifying  
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Figure 10. Type 1 and type 2 larval neuroblast lineages 
(A) Type 1 lineages are found in the CB and the VNC of larval brains. Type 2 lineages are localized on 
the posterior side of each brain lobe. (B) Each type 1 lineage is composed of a single Mira+Ase+Dpn+ 
neuroblast that divides asymmetrically into another neuroblast and an Ase+ GMC. Each GMC produces 
two Elav+ neurons. (C) Each type 2 lineage is composed of a single Mira+Ase-Dpn+ neuroblast that 
divides into another neuroblast and an immature intermediate neural progenitor (imm. INP). Imm. INPs 
are first Mira+Ase-Dpn-, then Mira+Ase+Dpn- and become mature when reaching the Mira+Ase+Dpn+ 
stage (this process is called maturation). Mature INPs divide several times into an INP and a GMC. 
Each GMC produces two Elav+ neurons. (D) In type 1 neuroblast ACD, Numb, Brat and Prospero 
segregate into the GMC. (E) In type 2 neuroblast ACD, Numb and Brat segregate into the imm. INP. (F) 
In mature INP ACD, Numb, Brat and Prospero segregate into the GMC. 
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cells that have the potential to produce several GMCs each. However, newly born INPs, 
which express Mira but lack Dpn and Ase, are mitotically inactive and called immature INPs 
(imm. INPs) (Bowman et al., 2008; Boone and Doe, 2008). In order to produce GMCs, they 
need to undergo a process called maturation, to sequentially express Ase, then Dpn (Bowman 
et al., 2008; Boone and Doe, 2008; Bayraktar et al., 2010). Once INPs express both nuclear 
proteins, they are called mature INPs and divide several times into another INP and a GMC, 
which this time inherits Mira, Brat, Numb and Pros (Fig. 10F) (Bowman et al., 2008; Boone 
and Doe, 2008; Bello et al., 2008; Bayraktar et al., 2010). Similarly to type 1 GMCs, type 2 
GMCs divide symmetrically into two neurons. 
 
As explained here, a set of markers (Mira, Ase, Dpn and Elav) is available to clearly identify 
all cells types that constitute type 2 lineages. However, the mechanisms that control type 2 
lineage progression, and especially INP maturation, remain unclear. 
 
5.1.2. Searching for novel regulators of neuroblast lineages: Identification of barricade 
In order to identify novel regulators of neuroblast lineage progression, we made use of a 
neuroblast genome-wide RNAi (RNA interference) screen that was recently conducted in our 
laboratory (for more details about the screen, see (Neumuller et al., 2011)). 
 
5.1.2.1. Genome-wide RNAi screen in neuroblasts: principle, workflow and 
phenotypic categories 
In this screen, the function of individual genes was assessed by RNAi-mediated knock down, 
in neuroblast lineages only. This tissue specificity was made possible by the use of the 
Gal4/UAS system (Fig. 11A). 
 
The Gal4/UAS system is widely used in Drosophila and relies on transgenic expression of the 
yeast transcription activator GAL4, that can bind UAS motifs to stimulate transcription of a 
sequence fused to it (Brand and Perrimon, 1993). For example, tissue specific expression of 
GAL4 combined with a UAS-RNAi construct, allows knocking down a chosen gene in a 
desired tissue. In the case of this screen, insc-Gal4 was used to express UAS constructs in 
neuroblast lineages, specifically. To optimize screening conditions, insc-Gal4 was combined 
with UAS-CD8::GFP (membrane tethered GFP), which enables the visualization of cells 
within neuroblast lineages, and with UAS-Dicer-2, which enhances RNAi (Dietzl et al., 
2007). This fly line is referred to as “driver line” because GAL4 drives expression of UAS 
constructs. To test the function of single genes on a genome-wide level, the GD RNAi library  
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Figure 11. Genome-wide in vivo RNAi screen to identify novel regulators of self-renewal and 
neuroblast lineage progression 
(A) Principle of the GAL4/UAS system used in the screen. GAL4 is fused to the promoter of insc (insc-
Gal4), allowing GAL4 expression in neuroblast lineages. GAL4 activates transcription of a membrane 
tethered GFP (UAS-CD8::GFP), and of an inverted repeat sequence that drives RNAi against a chosen 
gene (UAS-RNAi), leading to its knock-down in neuroblast lineages. (B) Workflow of the genome-wide 
RNAi screen. (C) Viability and lethality rates of crosses in the primary genome-wide screen. Lethal and 
semi-viable crosses were chosen for further analysis. Early lethal crosses could not be analyzed further 
because individuals died before the third instar larvae stage. (D) Most interesting phenotype categories 
observed in the screen: underproliferation (shorter lineages and/or less neuroblasts) and 
overproliferation (more neuroblasts/INPs). (E) Interaction network of genes causing overproliferation. 
Genes are represented as nodes and their color intensity reflects the strength of their RNAi phenotype. 
Lines that connect nodes represent known interactions or associations of the nodes 
(Genetic/Biochemical interaction and/or literature association). Line thickness reflects the amount of 
evidence for interaction between two nodes. (B,C,E) are adapted from (Neumuller et al., 2011). 
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of the Vienna Drosophila RNAi collection (VDRC) was used. Each one of the GD RNAi lines 
contains a short gene fragment cloned as an inverted repeat and fused to a UAS (Dietzl et al., 
2007). Upon transcription in neuroblast lineages, this fragment forms a hairpin that ultimately 
drives RNAi against this gene and knocks it down. 
 
The rationale of the screen was that if a gene is required in neuroblast lineages, its knock 
down with insc-Gal4 should result in lethality prior to adult stages. For that, females of the 
driver line were crossed to males of the GD RNAi library (Fig. 11B). When a cross was viable, 
the GD RNAi line was discarded. When a cross was lethal prior to adulthood or semi viable, 
third instar larvae were dissected, their brains were imaged (GFP signal) and potential 
phenotypes were annotated. A total of 17362 GD lines were tested in the primary screen 
(12314 genes), therefore covering about 89% of all annotated Drosophila protein coding 
genes. Among crosses of the primary screen, 4182 were lethal or semi viable (24.1%, 3412 
genes), and larval brain imaging revealed phenotypes in 832 lines (687 genes) (Fig. 11C). 
These 832 lines were then filtered using a quality criterion. Indeed, RNAi mediated by double 
stranded RNA (dsRNA) can potentially target several genes – off-target – and this is evaluated 
by the so-called “S19” score, where 0 reflects absence of specificity and 1, complete 
specificity (Kulkarni et al., 2006; Dietzl et al., 2007). Lines with S19>0,85 where considered 
for final phenotypical analysis, hence generating a list of 620 candidate lines, corresponding 
to about 4.5% of all Drosophila protein coding genes. 
 
Larval brain phenotypes observed in these 620 lines were very diverse. To precisely describe 
the phenotype of each line, criteria such as number, size and shape of 
neuroblasts/INPs/GMCs or formation of GFP aggregates were scored from 0 to 10 to reflect 
phenotypical strength. Most of these 620 lines could then be grouped in two separate 
categories, depending on their phenotype: “underproliferation” when then showed fewer 
neuroblasts and “overproliferation” when then showed too many neuroblasts or GMCs (Fig. 
11D). 
 
The underproliferation category is very likely to contain genes required for maintaining stem 
cell renewal, as one would expect that their knock down results in fewer neuroblasts. 
However, this category is also expected to contain a large number of housekeeping genes, 
which should also result in fewer cells. Indeed, the underproliferation category is very large 
and contains 538 genes. 
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The overproliferation category, however, should contain genes required for differentiation 
and lineage progression, since their knock down would result in more neuroblasts or INPs. 
This category is therefore the one we became interested in. Surprisingly, this group only 
contains 29 lines and after staining with Mira (neuroblast/INP) and Pros (GMCs/neurons), 18 
genes were confirmed to generate more neuroblasts/INPs upon knock down. 
 
5.1.2.2. Overproliferation network 
Interestingly, most of these 18 genes are known to interact with each other in a genetic and/or 
biochemical way. Together with information from the published literature, these data allowed 
to constitute an interaction network of the overproliferation genes (Fig. 11E). This network can 
be divided into two main sub networks: one containing genes involved in ACD and one 
containing genes involved in chromatin remodeling and transcription regulation. 
 
The ACD sub network is composed of 7 genes. This group contains the cell fate determinants 
Numb, Brat and Pros, and the adaptor protein Mira, which have all been shown to generate 
overproliferation upon knock down. Additionally, this group contains α-adaptin and AP-2σ, 
two members of the AP-2 complex that interacts with Numb, and the protein phosphatase 
PP4, which plays a role in Mira, Brat and Numb localization (Santolini et al., 2000; Berdnik 
et al., 2002; Sousa-Nunes et al., 2009). These genes were expected to give such phenotypes 
and validate the screening procedure. 
 
The chromatin remodeling and transcription regulation sub network is composed of brahma 
(brm), osa, moira (mor), ssrp and CG6049. Brm, Osa and Mor are members of the chromatin 
remodeling Brm complex, which is related to the SWI/SNF complex (Papoulas et al., 1998). 
The mammalian SWI/SNF complex has been involved in tumor suppression and in regulating 
proliferation of neural stem cells (Reisman et al., 2009; Yoo and Crabtree, 2009). Ssrp is a 
subunit of the FACT complex, which promotes transcription elongation by destabilizing 
nucleosomes to allow for RNA polymerase II (RNA Pol II) to proceed (Belotserkovskaya et al., 
2004). The last member of this sub network is CG6049, a previously uncharacterized gene 
that was renamed barricade (barc), because of its role in preventing overproliferation 
(Neumuller et al., 2011). We therefore decided to study barc in order to determine how it 
regulates neuroblast lineages. Barc belongs to a conserved family of proteins that have been 
involved in transcription elongation and splicing. The structure of these genes and the 
function of its homologues are presented below. 
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5.1.3. The Barc/Tat-SF1/CUS2 family of proteins: Structure and functions 
Barc is the homologue of human Tat stimulating factor 1 (Tat-SF1) and yeast CUS2 (Yan et al., 
1998; Zhou and Sharp, 1996). The Barc/Tat-SF1/CUS2 family of genes is conserved in 
eukaryotes (Fig. 12). 
 
5.1.3.1. The Barc/Tat-SF1/CUS2 family of proteins 
The common structure to all members of this family is composed of a nuclear localization 
signal (NLS) and two RNA recognition motifs (RRMs). RRMs, also called ribonucleoprotein 
domains (RNPs) or RNA-binding domains (RBDs), are the most common eukaryotic RNA 
binding domains (for reviews, see (Kielkopf et al., 2004) and (Maris et al., 2005)). These 
domains of about 90 amino acids can bind single stranded RNA, DNA and in some cases 
proteins. RRMs are found alone or in several copies and are typically present in proteins that 
play a role in RNA-dependant processes. RRMs of both Tat-SF1 and CUS2 have been 
described as being very similar to RRMs found in the human proteins Ewing’s sarcoma (EWS) 
and Fused in sarcoma (FUS/TLS), two proteins associated with various solid human tumors 
(Yan et al., 1998; Zhou and Sharp, 1996; Rabbitts, 1994; Ladanyi, 1995; Rabbitts et al., 1993; 
Crozat et al., 1993; Sorensen et al., 1994; Delattre et al., 1992). 
 
CUS2 is mainly composed of the NLS and the two RRMs. All other proteins of this family, 
however, are longer and extend either on their N- or C-terminus. Proteins of A. thaliana, C. 
elegans and D. melanogaster extend on their N-terminus, whereas the mouse and human 
proteins have a rather short N-terminus extension but a very long acidic C-terminus. Apart 
from CUS2, all members of this family possess a short conserved region called Barc/Tat-SF1 
motif (BTS) (Neumuller et al., 2011). This motif has been shown to bind FF domains, which 
are present in several transcription and splicing factors (Smith et al., 2004). 
 
Our understanding about the function of this family of proteins comes from the study of 
human Tat-SF1, and to a lesser extend of yeast CUS2. This knowledge is summarized below. 
 
5.1.3.2. Functions of human Tat-SF1 and yeast CUS2 
Tat-SF1 was originally identified for its role in Human immunodeficiency virus type 1 (HIV-1) 
transcription (Zhou and Sharp, 1996). Tat-SF1 was then shown to play a general role in 
transcription elongation (Li and Green, 1998). Additionally, Tat-SF1 and CUS2 have been 
involved in splicing (Yan et al., 1998; Miller et al., 2011; Miller et al., 2009; Fong and Zhou, 
2001; Zhou and Sharp, 1996). The next few paragraphs briefly explain mechanisms 
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Figure 12. The Barc/Tat-SF1/CUS2 family of proteins 
These proteins all contain two RNA Recognition Motifs (RRMs) and an Nuclear Localization Signal 
(NLS). Additionally, most of them possess a Barc/Tat-SF1 (BTS) motif. Grey boxes represent low 
complexity regions. Adapted from (Neumuller et al., 2011). 
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regulating transcription elongation of both HIV and endogenous genes, as well as splicing 
and summarized knowledge about the role of Tat-SF1 and CUS2 in these processes. 
 
• Tat-SF1 stimulates HIV-1 transcription 
The HIV-1 retrovirus is the most virulent virus responsible for the deadly Autoimmune 
Deficiency Syndrome (AIDS). Following entry in a CD4+ lymphocyte or a macrophage, viral 
HIV-1 RNA undergoes reverse transcription and integrates into the cellular genome. To be 
able to propagate and infect other cells, multiple copies of HIV-1 RNA have to be produced. 
To achieve that, the provirus uses host RNA Pol II to transcribe its genome from its 5’ long 
terminal repeat (LTR) promoter. Upon transcription initiation, the 5’ end of the nascent RNA 
forms a stem-loop structure called Transactivation Response Element (TAR element). If not 
further stimulated, polymerase can only produce short transcripts that do not allow viral 
replication (Kao et al., 1987). Synthesis of full-length transcripts requires the viral protein Tat 
to interact with the TAR element and to recruit several cellular factors that drive processive 
elongation and allow HIV-1 replication (Fig. 13, for review see (Ott et al., 2011)). Two of 
these essential cellular factors are the Positive Transcription Elongation Factor b (P-TEFb) and 
Tat-SF1 (Mancebo et al., 1997; Wei et al., 1998; Zhu et al., 1997; Zhou et al., 1998; Zhou 
and Sharp, 1996). Depletion of either P-TEFb or Tat-SF1 is sufficient to inhibit HIV-1 Tat 
transactivation (Zhou and Sharp, 1996; Zhou et al., 1998; Zhu et al., 1997; Zhou et al., 
1998). 
 
The function of P-TEFb – whose main subunits are Cyclin T (CycT) and Cyclin Dependant 
Kinase 9 (CDK9) – in promoting HIV RNA elongation is dual and relies on a series of 
phosphorylations. On the one hand, P-TEFb phosphorylates the Negative Elongation Factor 
(NELF), which detaches from Pol II. On the other hand, it phosphorylates the DRB Sensitivity 
Inducing Factor (DSIF) and the carboxyterminal domain (CTD) of RNA pol II to promote 
processive elongation (Fig. 13, (Zhou and Yik, 2006; Ott et al., 2011)). The kinase activity of 
P-TEFb is essential for HIV-1 Tat transactivation since CDK9 depleted nuclear extracts are 
unable to trigger productive elongation (Zhu et al., 1997; Zhou et al., 1998). 
 
The mechanism by which Tat-SF1 regulates HIV-1 RNA elongation remains unclear. Tat-SF1 
has been shown to associate with P-TEFb via its subunit CDK9 (Zhou et al., 1998). 
Additionally, P-TEFb can phosphorylate Tat-SF1 in a CDK9-independent manner, suggesting 
that P-TEFb could regulate Tat-SF1 activity (Zhou et al., 1998). However, the importance of 
Tat-SF1 phosphorylation in regulating elongation has not been demonstrated so far. 
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Figure 13. Model for HIV-1 transcription elongation 
Upon transcription initiation, the nascent HIV-1 mRNA forms a stem-loop structure (TAR element). In 
the absence of the viral protein Tat, polymerase is paused and no full-length transcript is produced. In 
the presence of Tat and upon its binding to the TAR element, Tat recruits Tat-SF1 and P-TEFb. P-TEFb 
carries out a series of phosphorylation (NELF, DSIF, RNA Polymerase II carboxyterminal domain) and, 
together with Tat-SF1, stimulates processive elongation and production of full length HIV-1 mRNAs. 
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• Tat-SF1 promotes RNA Pol II elongation 
Interestingly, although Tat-SF1 was originally identified as a Tat-dependent activator of 
transcription, Tat-SF1 was later shown to activate transcription in a Tat-independent manner 
and is now considered a general elongation factor (Li and Green, 1998). Transcription 
elongation of endogenous protein coding genes was long thought to be mainly regulated at 
the level of RNA Pol II recruitment and transcription initiation. However, observations made 
at the promoter of Drosophila heat shock and mammalian c-myc genes, revealed that 
although Pol II was engaged in transcription, it was paused after synthesizing around 25-50 
nucleotides (Gilmour and Lis, 1986; Bentley and Groudine, 1986; Rougvie and Lis, 1988; 
Krumm et al., 1992; Strobl and Eick, 1992; Rasmussen and Lis, 1993). This phenomenon is 
referred to as Pol II promoter-proximal pausing (PPP) and was initially considered to be 
happening at very few genes. However, over the last couple of years Pol II PPP was observed 
at a very large number of Drosophila and mouse loci, and pausing release is now considered 
a critical step in the regulation of elongation (Muse et al., 2007; Zeitlinger et al., 2007; Core 
et al., 2008; Lee et al., 2008; Nechaev et al., 2010). Interestingly, control of Pol II PPP-release 
seems to be particularly important for genes involved in development and stimulus-response 
(for review, see (Nechaev and Adelman, 2010) and (Levine, 2011)). 
 
When paused after having transcribed 25-50 nucleotides, RNA Pol II is associated with NELF 
and DSIF, which at this point inhibit productive elongation (Fig. 14). In a similar way to HIV-
1 transcription, productive elongation requires intervention of P-TEFb, which phosphorylates 
NELF, DSIF and the CTD of Pol II to allow for PPP-release. Additionally, different complexes 
associate with Pol II to stimulate productive elongation. Among them are the Paf1 complex 
(Paf1C) and Tat-SF1 (Zhu et al., 2005; Kim et al., 1999). Paf1C acts at least partially through 
modifying histones during elongation both in Drosophila and humans (Zhu et al., 2005; 
Adelman et al., 2006). Tat-SF1 binds to Pol II, Paf1C and DSIF, and its activity depends on 
Paf1C and DSIF (Kim et al., 1999; Chen et al., 2009). Although Tat-SF1 associates with all 
these proteins to stimulate elongation, its precise mechanism of action remains unclear. 
 
• Tat-SF1, CUS2 and precursor mRNA splicing 
A few observations suggest that Tat-SF1 and CUS2 are involved in splicing, the process of 
removing introns from precursor mRNAs. With the rare exception of self-splicing introns, 
splicing requires both a series of specific intronic sequences and a conserved machinery 
called the spliceosome (for reviews, see (Will and Luhrmann, 2011; Burge et al., 1999)). 
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Figure 14. Model for the regulation of Polymerase Promoter-Proximal Pausing (PPP) and transcription 
elongation 
RNA polymerase II is recruited to the promoter of a gene and initiates transcription. Shortly after 
transcription initiation, polymerase pauses. At this point, polymerase is phosphorylated on Serine 5 of 
its carboxyterminal domain (CTD) and associated with NELF and DSIF. Release from this paused state 
is mediated by P-TEFb, which phosphorylates NELF (to inhibit it), DSIF (to activate it) and Serine 2 of 
the polymerase CTD. Together with the recruitment of elongation factors such as Tat-SF1 and Paf1C, 
polymerase can resume processive elongation to produce full-length mRNAs. 
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Each intron is defined by several motifs required for its excision: a 5’ splice site (ss), a 3’ss and 
a branch point. 5’ and 3’ss are sequences found on each end of the intron and serve as 
intronic boundaries. The branch point sequence is usually located 18 to 40 nucleotides 
upstream of the 3’ss and contains an adenosine residue that is essential for splicing to take 
place (Fig. 15A). 
 
The spliceosome is a large machinery composed of several small nuclear ribonucleoproteins 
(snRNPs). Each snRNP is composed of a small nuclear RNA (snRNA) and of several proteins. 
In Eukaryotes, the vast majority of splicing events are carried out in the nucleus by the so-
called U2-dependant or major spliceosome, which is composed of the U1, U2, U5 and U4/6 
snRNPs (Will and Luhrmann, 2011). UsnRNPs recognize intronic sequences and, through a 
series of rearrangements, they carry out two successive transesterifications that ultimately lead 
to excision of the intron as a lariat, and junction of the two flanking exons (Fig. 15B). 
 
CUS2 was proposed to be a splicing factor based on two main observations. First, CUS2 was 
shown to bind RNA via its first RRM and to interact with U2snRNA (Yan et al., 1998). 
Second, a yeast two-hybrid experiment revealed that it binds to PRP11, a subunit of the 
U2snRNP complex (Yan et al., 1998). However, absence of CUS2 does not seem to impair 
splicing under normal condition and seems to be required in challenging environments (Yan 
et al., 1998). 
 
Tat-SF1 was shown to interact with all five UsnRNAs of the spliceosome via its first RRM and 
with SF3a66/SAP62, the human homologue of PRP11 (Fong and Zhou, 2001; Zhou and 
Sharp, 1996). Knock down of Tat-SF1 has been shown to increase the unspliced/spliced ratio 
of HIV transcripts and to have an effect on cellular genes both at the level of transcription and 
splicing (Miller et al., 2009; Miller et al., 2011). 
 
In summary, proteins of the Barc/Tat-SF1/CUS2 family have been implicated in regulating 
transcription elongation and/or splicing through mechanisms that remain elusive. Although 
control of elongation is considered to be particularly important for genes involved in 
development, there are very few examples of genes regulating this process and causing 
developmental defects. The Drosophila member of this family, barc, was identified in a 
genome wide RNAi screen for defects in larval brain development. A preliminary analysis of 
its phenotype, conducted together with the screen, revealed that it mainly affects INPs of type  
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Figure 15. Splicing in yeast and metazoans: intronic sequences and basic mechanism 
(A) Eukaryotic introns contain three sequences required for splicing: a 5’ splicing site (ss), a 3’ ss and a 
branch point. Introns of higher eukaryotes additionally contain a pyrimidin tract. (B) Basic mechanism 
of splicing by the U2 spliceosome. First, U1 and U2 snRNPs bind to the 5’ss and the branch point, 
respectively. Then, they recruit U5 and U4/U6 snRNPs to the intron. At this point, a series of 
rearrangments takes place between intronic sequences and snRNPs that lead to the release of U1 and 
U4 snRNPs. U2, U5 and U6 snRNPs then carry out 2 transesterifications that lead to the junction of the 
two flanking exons and the release of the intron as a lariat. Adapted from (Will and Luhrmann, 2011). 
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2 lineages (Neumuller et al., 2011). Our study confirms and largely extends beyond this 
finding, characterizing barc and aiming at understanding how it regulates neuroblast lineages. 
 
5.2. RESULTS 
5.2.1. Phenotypical analysis of barc knock down in larval brains 
In the genome wide screen, RNAi-mediated knock down of barc using insc-Gal4 resulted in 
lethality and generation of more neuroblast/INPs in larval brains. The GD RNAi line that 
generated this phenotype is called “Transformant ID 25497” in the VDRC collection. Since it 
is the only GD RNAi line designed against barc, in this chapter we will call it UAS-
barcRNAiGD or simply barc GD RNAi. Our first aim was to precisely describe the barc RNAi 
phenotype in order to determine how it affects neuroblast lineages. 
 
5.2.1.1. The barc RNAi phenotype is specific 
We first looked at the effect of barc knock down in both type 1 and type 2 lineages, using 
insc-Gal4, and staining for the neuroblast/INP marker Mira (Fig. 16). Our first observation was 
that barc GD RNAi brains have an increased number of Mira+ cells on the posterior side of 
the brain lobe, compared to wild type controls (Fig. 16A-A’’ & 16B-B’’). This result suggests 
that knock down of barc generates more neuroblasts or INPs. The s19 score of the barc GD 
RNAi construct is 1, which means that it is predicted to be completely specific. However, to 
rule out that the phenotype is caused by an RNAi off-target effect, we used a second RNAi 
line (UAS-barcRNAiCustom) that targets a non-overlapping fragment of the barc mRNA (Fig. 
16C-C’’ & 16F). Using this line, we observed the same phenotype than we did with UAS-
barcRNAiGD, confirming that barc is indeed responsible for the observed phenotype. We then 
wanted to test whether the RNAi phenotype could be rescued by re-expressing Barc. For that, 
we co-expressed barricadeRes-FL, an RNAi resistant full-lenght barc construct, together with the 
GD RNAi construct (Fig. 16F) (Neumuller et al., 2011). Interestingly, these flies survived until 
adulthood and their larval brains did not show a phenotype (Fig. 16D-D’’). One could argue 
that this rescue comes from a weaker RNAi knock down of barc caused by the fact that insc-
Gal4 has to drive one more UAS construct (UAS-barcRes-FL). To rule this out, we tried to rescue 
the RNAi phenotype with UAS-CD8::GFP. As expected, these flies died before adulthood, 
indicating that the rescue indeed comes from re-expression of Barc, and not weaker knock 
down. Additionally, a version of Barc lacking its two RRMs and its NLS (barricadeRes-∆RRM1&2) 
was also unable to rescue the RNAi phenotype and showed an accumulation of Mira+ cells  
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Figure 16. barc knock down leads to an accumulation of Mira+ cells in larval brains 
(A-E”) Third instar brains expressing insc-Gal4>>CD8::GFP and labeled with indicated markers. Brains 
expressing either barc GD RNAi (B-B’’) or barc Custom RNAi (C-C’’) show an accumulation of 
progenitors (Neuroblasts/INPs, Mira+) in the dorsomedial part of the brain, compared to brains 
expressing no RNAi (A-A’’). This phenotype can be rescued by co-expression of barc GD RNAi and 
barcRes-FL (D-D’’) but not barc GD RNAi and barcRes-ΔRRM1&2 (E-E’’). Progenitors of type 2 lineages 
(Mira+) are highlighted (dashed line). Adult survival/lethality of each genotype is indicated in the lower 
grey boxes. (F) Schematic representing barcRes-FL, barcRes-ΔRRM1&2 and the regions targeted by the GD 
and the Custom barc RNAi lines. 
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on the posterior side, indicating that the function of Barc is carried out by its RRMs and/or its 
nuclear localization (Fig. 16 E-E’’ & 16F). 
 
Taken together, these results indicate that the accumulation of Mira+ cells observed upon 
RNAi knock down is specific to barc. 
 
5.2.1.2. barc RNAi strongly affects type 2 neuroblast lineages 
Interestingly, these groups of Mira+ cells are found precisely where type 2 lineages are 
located, which prompted us to examine whether this phenotype originates in these lineages. 
To test that, we knocked down barc in all lineages using insc-Gal4 and stained larval brains 
with Ase. As mentioned earlier, Ase is expressed in type 1 neuroblasts but is absent in all 
eight type 2 neuroblasts (Fig. 17A-A’). Stainings of barc RNAi knock down brains revealed 
that the severe Mira phenotype indeed originates in type 2 lineages (Fig. 17B-B’ & C-C’). 
Careful analysis of these stainings unraveled that these large groups of Mira+ cells are 
composed of two to three type 2 lineages, that each possess a single Mira+Ase- neuroblast 
and a large number of Mira+Ase+ cells of intermediate size. The fact that the majority of the 
cells that accumulate in barc RNAi type 2 lineages express both Mira and Ase suggests that 
they are in fact INPs (for detailed analysis, see below). 
 
Taken together, these data indicate that barc is important in type 2 neuroblast lineages where 
it prevents from accumulation of INPs. 
 
5.2.1.3.  barc RNAi leads to an accumulation of INPs at the expense of neurons 
We next wanted to determine whether barc deficient type 2 lineages are able to produce 
terminally differentiated neurons. To test this, we co-stained these lineages with Mira 
(neuroblasts/INPs) and Elav (neurons) (Fig. 18A). A wild type lineage (traceable with UAS-
CD8::GFP) contains a single large Mira+Elav- neuroblast, a curved chain of Mira+Elav- INPs, a 
few Mira-Elav- GMCs and a large number of Mira-Elav+ neurons (Fig. 18B). In lineages 
expressing barc GD or Custom RNAi, however, virtually all cells are Mira+Elav-, indicating 
that these lineages are unable to produce neurons (Fig. 18C&D). As expected, lineages 
rescued by expression of UAS-barcRes-FL are able to produce neurons just like in a wild type 
situation (Fig. 18E). 
 
These data indicate that barc RNAi type 2 lineages accumulate INPs that are unable to 
produce neurons. 
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Figure 17. The accumulation of Mira+ cells observed with barc RNAi originates in type 2 lineages 
(A-C’) Third instar brains expressing insc-Gal4>>CD8::GFP and labeled with indicated markers. (A,A’) 
Control brains have eight type 2 neuroblast per lobe (Mira+Ase-, closed arrowhead, not all type 2 
neuroblasts are in focus) and a large number of type 1 neuroblasts (Mira+Ase+, open arrowhead). Mira+ 
cells accumulating in brains expressing either barc GD RNAi (B-B’) or barc Custom RNAi (C-C’) 
originate from type 2 neuroblasts (closed arrowhead) and not type 1 neuroblasts (open arrowhead). 
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Figure 18. barc knock down causes defects in type 2 lineage progression 
(A,F,J) Schematic representation of the expression pattern of the markers used in immunostainings (B-
E,G-I,K-M’) of  type 2 lineages from third instar brains expressing insc-Gal4>>CD8::GFP. (A-E) 
Analysis of Mira/Elav expression. A lineage expressing no RNAi (B) is composed of a single Mira+Elav- 
neuroblast (closed arrowhead), a curved chain of Mira+Elav- INPs and a large number of Mira-Elav+ 
neurons. Lineages expressing either barc GD (C) or barc Custom RNAi (D) cluster in groups of 2-3 that 
are each composed of a single Mira+Elav- neuroblast (closed arrowhead), a large number of Mira+Elav- 
INPs and no Mira-Elav+ neurons. This phenotype can be rescued by co-expression of barc GD RNAi 
and barcRes-FL (E). Lineages are highlighted by a dashed line. (F-I) Analysis of Mira/Ase expression. A 
lineage expressing no RNAi (G) is composed of a single Mira+Ase- neuroblast (closed arrowhead), 
about 2 Mira+Ase- imm. INPs (open arrowhead) and a chain of Mira+Ase+ INPs. In lineages expressing 
either barc GD (H) or barc Custom RNAi (I), Ase is not affected. Progenitors (Neuroblasts/INPs) are 
highlighted by a dashed line. (J-M’) Analysis of Mira/Dpn expression. A lineage expressing no RNAi (K) 
is composed of a single Mira+Dpn+ neuroblast (closed arrowhead), about 4 Mira+Dpn- imm. INPs 
(empty arrowhead), and a large number of Mira+Dpn+ mat. INPs. (closed arrowhead). Lineages 
expressing either barc GD (L) or barc Custom RNAi (M) each contain a Mira+Dpn+ neuroblast (closed 
arrowhead), but far too many Mira+Dpn- imm. INPs (empty arrowhead). Deeper inside these lineages, a 
few Mira+Dpn+ mat. INPs. (L’,M’, closed arrowhead) can be observed. Progenitors (Neuroblasts/INPs) 
are highlighted by a dashed line. (O) Imm. INPs of lineages expressing barc GD RNAi (called B, n=34, 
from 3 brain lobes) are bigger than those of lineages expressing no RNAi (called C, n=37, from 4 brain 
lobes). SEM, t-test pvalue<0,001. (P-Q) In type 2 lineages expressing barc RNAi (Q), a large number of 
imm. INPs and a few mat. INPs accumulate at the expense of neurons, compared to lineages 
expressing no RNAi (P). 
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5.2.1.4. barc regulates INP maturation 
We next wanted to determine whether INPs that accumulate in barc deficient type 2 lineages 
are immature or mature. These two different populations of cells can be distinguished based 
on the expression of Ase and Dpn: young immature INPs are Ase-Dpn-, old immature INPs 
are Ase+Dpn- and mature INPs are Ase+Dpn+. It is important to keep in mind that the 
neuroblast always divides in the same orientation and that INPs do not migrate. Young INPs 
are therefore close to the neuroblast, whereas old INPs are far away from it. 
 
We started our analysis by looking at Mira and Ase. A wild type lineage typically contains a 
single Mira+Ase- neuroblast and two to three Mira+Ase- INPs next to it, all other INPs being 
Mira+Ase+ (Fig. 18F&G). In both barc GD and Custom RNAi type 2 lineages, Ase had a 
similar expression pattern than in the wild type situation (Fig. 18H&I). This result indicates 
that Ase expression is not affected by loss of barc and that INPs that accumulate in these 
lineages are not young immature INPs. 
 
To determine whether these INPs are old immature or mature INPs, we then stained these 
lineages with Mira and Dpn. A wild type lineage typically contains a single Mira+Dpn+ 
neuroblast, about four to five Mira+Dpn- immature INPs, and more Mira+Dpn+ mature INPs 
farther away from the neuroblast (Fig. 18J&K). Upon barc knock down with either the GD or 
the Custom RNAi construct, we observed that although the neuroblast still expresses Dpn, the 
majority of Mira+ cells are Dpn- indicating that they are immature INPs (Fig. 18L&M). It is 
important however, to note that a few cells located far away from the neuroblast do re-
express Dpn, indicating that these few cells eventually manage to reach a mature INP state 
(Fig. 18L’&M’). 
 
Another interesting observation made based on these stainings, is that barc RNAi immature 
INPs (8,23µm ±0,23µm, n=34 from 3 brain lobes; SEM) are significantly larger than wild-type 
immature INPs (6,02µm ±0,14µm, n=37 from 4 brain lobes; SEM) (Fig. 18O). 
 
Taken together, these data demonstrate that upon barc knock down, immature INPs grow and 
most of them remain in an immature INP state, failing to re-express Dpn (Fig. 18P&Q). This 
suggests that Barc is a novel regulator of INP maturation. 
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5.2.1.5. Quantification of the barc RNAi phenotype in type 2 lineages 
We next wanted to quantify the accumulation of immature INPs in barc RNAi lineages. When 
we induce barc RNAi with insc-Gal4, all lineages express GFP and type 2 lineages cluster 
together, making it very hard to confidently count cells. To circumvent this problem, we 
decided to use the type 2 specific driver line worniu-Gal4, asense-Gal80 (wor-Gal4, ase-
Gal80, Fig. 19A) (Neumuller et al., 2011). RNAi-mediated knock down of barc with this 
driver line resulted in lineages that mainly consist of Mira+ cells, similarly to what we 
observed with insc-Gal4 (Fig. 19B). We then stained these lineages with Mira and Dpn and 
observed that barc RNAi lineages have more Mira+Dpn- immature INPs than wild type 
lineages (Fig. 19C-C’,D-D’). 
 
When counting Mira+ cells of wild type lineages, we noticed that type 2 lineages are 
heterogeneous in terms of the amount of INPs they each produce. Indeed, the two dorsal 
lineages systematically generate less INPs than the six medial lineages (dorsal: 9,66 ±2,99 
INPs/lineage; medial: 32,08 ±4,90 INPs/lineage; n=6 lobes; SD; Fig. 19A,E). All wild type 
medial lineages, however, seem to generate a similar number of INPs. For that reason, we 
decided to count INPs generated by the six medial lineages, solely. 
 
Upon barc RNAi knock down, we observed a significant accumulation of INPs in type 2 
lineages  (Control: 32,08 ±0,81 INPs/lineage; barc: 42,19 ±0,92 INPs/lineage; n=36 lineages 
each; SEM; Fig. 19F). The effect of losing barc was much stronger on immature INPs, than on 
mature INPs (Control: 4,72 ±0,11 Mira+Dpn- cells and 27,36 ±0,80 Mira+Dpn+ cells; barc: 
9,52 ±0,34 Mira+Dpn- cells and 32,66 ±0,89 Mira+Dpn+ cells; n=36 lineages from 6 brain 
lobes each; SEM; Fig. 19F). This quantification confirms our previous observation that barc 
regulates INPs (Fig. 19G). However, the number of INPs that reach a mature stage is much 
higher when knocking down barc with wor-Gal4, ase-Gal80 than with insc-Gal4. This 
observation might first seem a bit surprising. However, it is important to remember than barc 
knock down does not affect Ase. This means that as soon as an immature INP turns on Ase, 
Gal80 is expressed, represses Gal4 and turns off expression of the RNAi construct. In other 
words, with this driver line barc RNAi is only expressed in the neuroblast and the two to three 
youngest immature INPs. The very transient activity of wor-Gal4, ase-Gal80 in a barc RNAi 
background is probably responsible for the weaker phenotype observed with this driver line 
compared to insc-Gal4 (Fig. 19H). 
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Figure 19. Quantification of the barc RNAi phenotype using a type 2 lineage specific driver line 
Overview (A,B) and close-ups (C-D’) of third instar brains expressing wor-Gal4,ase-Gal80>>CD8::GFP 
in the 8 type 2 lineages (A,B: 6 medial lineages (called M, dashed line) and 2 dorsal lineages (called D, 
empty arrowhead). Lineages expressing barc GD RNAi (B,D,D’) have more Mira+Dpn- imm. INPs 
(open arrowhead, D,D’) than lineages expressing no RNAi (A,C,C’). Asterisk: Mira+Dpn+ neuroblast. 
Closed arrowhead: regular Mira+Dpn- imm. INPs. Lineages are marked with a dashed line. (E) Wild 
type dorsal lineages (called D) produce much less INPs/lineage than medial lineages (called C). SD, 
n=6 lobes. (F) Quantification of imm. INPs (Mira+Dpn-), mature INPs (Mira+Dpn+) and total INPs per 
medial lineages expressing barc GD RNAi (called B) or no RNAi (called C). n=6 lobes, SEM, t-test 
pvalue<0,001. (G) Type 2 lineages expressing barc GD RNAi have more imm. and mature INPs. (H) 
The weaker phenotype observed with wor-Gal4,ase-Gal80>>CD8::GFP is probably due to the fact that 
with this driver line, the RNAi is only expressed in 3-4 cells, until Ase turns on. 
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Figure 20. barc is also important in type 1 lineages.  
(A) Type 1 neuroblasts expressing barc GD RNAi (called B, n=72, from 8 lobes) are bigger than those 
expressing no RNAi (called C, n=55, from 8 lobes). SEM, t-test, pvalue<0,001. Overview (A,D) and 
close-ups (C,E) of the anterior side of third instar brains expressing insc-Gal4>>CD8::GFP and labeled 
with indicated markers. Wild-type type1 neuroblasts (C) produce GMCs/neurons (Pros+, closed 
arrowhead) that are largely missing upon expression of barc GD RNAi (E). OL: Optic lobe. (F-H) 
Close-up on dividing type 1 neuroblasts. Asymmetric localization of Mira in metaphase (F) is not 
affected by expression of either barc GD (G) or barc Custom RNAi (H). 
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5.2.1.6. barc also plays a role in type 1 lineages 
We then wanted to test whether barc is also required in type 1 lineages. We therefore looked 
at these lineages on the anterior side of the brain, using Mira to mark neuroblasts and Pros to 
visualize GMCs and neurons. Our first observation was that barc RNAi type 1 neuroblasts are 
significantly larger than their wild-type counterparts (wild type: 12,81µm ±0,23µm diameter, 
n=55 from 8 brain lobes; barc: 15,71µm ±0,23µm diameter, n=72 from 8 brain lobes; SEM; 
Fig. 20A). Since larval neuroblasts regrow between each division, an increase of their size 
upon barc knock down suggests that Barc affects either growth or cell cycle. Strikingly, we 
observed less Pros+ cells in barc type 1 lineages, compared to wild type lineages (Fig. 20B-E). 
This suggests that in barc RNAi brains, type 1 neuroblasts or GMCs fail to produce a proper 
amount of neurons. Although we could not precisely quantify a potential effect of barc on 
cell cycle using insc-Gal4, we did observe that barc RNAi type 1 neuroblast do divide in an 
asymmetric way (Fig. 20F-H). 
 
Taken together, these data demonstrate that barc is also required in type 1 lineages, where it 
affects growth and possibly cell cycle, and is ultimately required to produce neurons. 
 
5.2.2. Characterization of Barc expression pattern 
Having shown that Barc plays a role in both type 1 and type 2 lineages, we became interested 
in determining in which cell types is Barc expressed, and whether it could play a role in other 
tissues as well. For that, we raised antibodies against the C-terminus of the protein, in both 
rabbits (Neumuller et al., 2011) and guinea pigs (this study). 
 
5.2.2.1. Barc is strongly expressed in larval neuroblasts 
Since we know Barc is important in neuroblast lineages, we decided to test our antibodies in 
larval brains first. 
 
Western blots of larval brain protein extracts, revealed that our purified rabbit antibody 
recognizes a single band that runs around 75kDa (Fig. 21A). Barc is predicted to be 64kDa, 
however, just like it has been reported for human Tat-SF1, its very acidic sequence is 
probably responsible for the fact that it runs higher in SDS-PAGE (Zhou and Sharp, 1996). 
This antibody additionally recognized overexpressed Myc::Barc in western blots (Fig. 21A). 
 
When we stained larval brains with our antibodies, we observed a very strong nuclear signal 
in both type 1 and type 2 neuroblasts and to a lesser extend in INPs and differentiated cells  
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Figure 21. Barc expression pattern in the larval brain 
(A) Western blot of larval brain extracts. Purified rabbit α-Barc recognizes a single band that runs at 
about 75kDa as well as overexpressed Myc::Barc. (B-I) Third instar brains expressing wor-Gal4,ase-
Gal80>>CD8::GFP or insc-Gal4>>CD8::GFP. Barc is a widely expressed nuclear protein (B,B’,D,D’) 
that shows a prominent signal in all neuroblasts (F,H, closed arrowhead) and to a lesser extent in INPs 
(F,H, empty arrowhead) and differentiated cells. Our antibodies are specific to Barc since they 
recognize overexpressed Myc::BarcRes-FL (C-C’’) and that their signal is lost upon barc RNAi expression 
(E,E’,G,I). In (E’) compare areas where barc RNAi is expressed (empty arrowhead), to areas where barc 
RNAi is not expressed (closed arrowhead). 
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(Fig. 21B-B’’, D-D’, F&H). This signal is specific to Barc because our antibodies recognize 
overexpressed Myc::Barc and this signal is lost upon RNAi knock down (Fig. 21C-C’’, E-E’, 
G&I). 
 
Taken together these data show that our antibodies are specific and reveal that Barc is 
strongly expressed in neuroblasts but is also present in all other cells. 
 
5.2.2.2. Barc is also expressed in embryos and germline stem cell lineages 
Having good antibodies in hand, we next wanted to ask whether Barc is specifically 
expressed in larval brains or whether it is also present in developing embryos and other stem 
cell lineages, such as the ovaries and testes. 
 
We first tested our antibodies in western blot on embryo extracts. Just like for larval brain, our 
antibodies recognized a 75kDa band, suggesting Barc is also expressed in embryos (Fig. 22A). 
We therefore stained embryos of different age to determine which cells or tissues express 
Barc. In early embryos, prior to cellularization, somatic nuclei are located at the periphery of 
the embryo, whereas nuclei of pole cells, the germline precursors, are found at the posterior 
end of the embryo. At this stage, we found that Barc localizes to all nuclei (Fig. 22B,B’,C,C’). 
In late embryos, we found Barc to be also expressed in all nuclei (Fig. 22D,D’). 
 
We then wanted to test whether Barc is expressed in stem cell lineages of the ovaries and the 
testes. In both these lineages, stem cells are in contact with a niche, composed of somatic 
cells – Cap cells (CCs) for ovaries and Hub for testes, that maintains them in a self-renewing 
state. Germline stem cells (GSCs) of both tissues produce cells – Cystoblasts (CBs) for ovaries 
and Gonialblasts (GBs) for testes – that are not in contact with the niche anymore, 
differentiate and divide to ultimately produce gametes (Fig. 22E&H). Interestingly, Barc seems 
to be expressed in virtually all cells that populate ovaries and testes (Fig. 22F,F’,G,G’,I,I’,J,J’). 
 
Taken together, these data show that Barc is broadly expressed during embryonic 
development as well as in ovaries and testes. This favors the idea that Barc is a nuclear 
regulator that plays a role in a variety of tissues and organs in Drosophila. 
 
5.2.3. Generation of a barc mutant and of rescue constructs 
Using an inducible mutant is an optimal way to confirm an RNAi phenotype, precisely 
quantify an effect on cell fate and cell cycle, and circumvent possible early lethality caused  
 
 
 
79 
 
Figure 22. Expression pattern of Barc in embryos, ovaries and testes 
(A) Western blot showing that Barc is expressed in embryos. (B-D’) Immunostainings of embryos. Barc 
localizes to the nucleus of all cells both in early (B-C’) and late (D,D’) embryos. Dashed lines in (C,C’) 
highlight the yolk mass found in the center of early embryos. Closed arrowheads indicate pole cells. 
Dashed lines in (D,D’) highlight the digestive tract. (E) Drosophila ovaries are composed of a 
germarium, where germline stem cells (GSCs) are located , and of egg chambers, where eggs develop. 
GSCs are in contact with a niche (cap cells, CC). When they divide, they generate a cystoblast (CB) 
that differentiates and divides to form the future egg. A developing egg is composed of an oocyte (OC) 
and support cells (SC) that are surrounded by somatic cells (follicular cells, FCs) produced by folicullar 
stem cells (FSCs) (F-G’) Immunostainings of ovaries. Barc is expressed in GSCs (closed arrowhead) as 
well as in most other cells of the ovaries. (H) In Drosophila testes, germline stem cells (GSCs) are also 
contact with a niche (Hub). They generate gonialblasts (GBs) that differentiate and divide to form the 
future spermatids (SPs). (I-J’) Immunostainings of testes. Barc is expressed in GSCs (closed arrowhead) 
as well as in most other cells of the testes. 
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by broad expression of the gene of interest. Because there was no barc mutant available, we 
decided to design our own, together with two different rescue constructs. 
 
5.2.3.1. Choice of the method to generate a barc mutant 
There are several well-established methods that allow generating mutants in Drosophila. 
However, most of them rely on the presence of transposable elements around the gene locus. 
In addition to lacking such element insertions, the barc locus is very complex. Indeed, barc 
overlaps with two other genes, on the opposite strand (rgn & CG33288, Fig. 23A). We 
therefore decided to use Ends-out homologous recombination, an elegant and versatile 
method based on the recognition of homologous sequences that allows removal and 
replacement of any part of a locus. The next few paragraphs resume the method used here 
but for details please refer to the “Experimental Procedures” section of this chapter and to 
(Rong and Golic, 2000; Huang et al., 2009). 
 
Ends-out homologous recombination requires cloning of DNA sequences flanking the region 
that one wishes to delete – called “homology arms”. These arms are placed on each side of a 
cassette that contains the selection marker white flanked by LoxP sites, which allow to 
remove the white gene if necessary. This construct is inserted in a white deficient fly on a 
different chromosome than the one carrying the gene of interest – this line is called “Donor” 
fly line. The construct is then artificially excised, and in rare cases homology arms recognize 
their endogenous counterparts and recombine. This leads to the replacement of the 
endogenous area of interest, with the white cassette and generates a mutant allele (Rong and 
Golic, 2000). 
 
5.2.3.2.  Making a barc mutant by homologous recombination: design of the strategy 
To maximize chances that our mutant is a null allele, we decided to delete all coding 
sequences that do not overlap with any other gene, namely exons 2 and 3, which contain the 
end of the 5’UTR, the unique ATG and about 60% of the barc coding sequence (Fig. 23A&B). 
The region to be deleted encodes the N-terminus, the BTS domain and 2/3rd of the first RRM 
of the protein. The deletion of this 1.4 kb region of the barc locus should therefore result a 
null mutant allele. 
 
We ultimately would like to replace this fragment with a cassette containing the selection 
marker white and a so-called minimal attP phage sequence (50bp) (Fig. 23A). This minimal 
attP sequence can specifically and efficiently recombine in Drosophila with the minimal  
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Figure 23. Generation of a barc mutant allele by ends out homologous recombination 
Schematic of the wild type barc (A) and barcattKO mutant (B) loci. We used an upstream homology arm 
(orange) of about 4 kb and a downstream homology arm (orange) of about 4.7 kb, to delete a 1,4kb 
fragment that contains the ATG of barc and about 60% of its coding sequence. We replaced it with a 
cassette containing an attP site and the selection marker white. barc is encoded by the minus strand 
and for sake of clarity the chromosome has been flipped over. 
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bacterial attB sequence (53bp), upon expression of the ϕ31 recombinase (Huang et al., 2009). 
From a theoretical point of view, having an attP sequence in the mutant locus enables to 
rescue the mutant with an attB-barc construct (for details about rescue constructs, see section 
5.2.3.4). From a technical point of view, however, one has to keep in mind that the insertion 
of attB-barc in the attP site would result in the formation of an attR and an attL sequence on 
each side of the insertion. To make sure that the attR formed upstream of the barc rescue 
coding sequence (barc CDS) would not interfere with splicing between exon 1 and barc CDS 
– as this could result in a failure to rescue the mutant – we decided to place the attP sequence 
in intron 1 rather than at the beginning of exon 2. Finally, the attP can also not be placed 
randomly in intron 1. Indeed, its insertion in the branch point sequence would also abolish 
splicing and prevent rescue of the mutant. The branch point is usually located 18 to 40 bp 
upstream of the 3’ splice site (ss) (Will and Luhrmann, 2011). We therefore decided to place 
the attP site about 140bp upstream of the 3’ ss. To ensure rescue, this deleted fragment of 
intron 1 would be inserted in the rescue constructs to ensure correct splicing between intron 
1 and barc CDS. 
 
In order to generate a barc mutant allele lacking the 1.4kb fragment described above, and 
having considered splicing issues, we cloned an upstream homology arm of about 4 kb that 
starts in intron 1, and a downstream homology arm of about 4.7 kb that starts a bit 
downstream of exon 3 (Fig. 23A&B).  
 
Finally, since Barc could have a role in a variety of tissues and that we would like to quantify 
its effect on cell fate and cell cycle, we wanted this mutant to be compatible with the 
MARCM system (Lee and Luo, 1999). This system, widely used in chapter I, allows the 
generation of traceable mutant clones in an otherwise heterozygous background. This method 
requires the mutant allele to possess an FRT sequence on the same chromosomal arm – in this 
case, FRT80B. This is usually achieved by recombining the FRT sequence with the mutant 
arm. However, barc is extremely close to FRT80B, rendering recombination very difficult. We 
therefore decided to generate our mutant allele directly on a chromosome carrying FRT80B. 
 
5.2.3.3.  Screening for mutant candidates 
To look for correct mutant, we first screened candidates for restored white function, located 
on the right chromosome, and lethal before adulthood. We then screened candidates by PCR, 
using primers in the white cassette, combined with primers that either bind the homology arm 
or the genomic sequence surrounding it (Data not shown). Finally, we used southern blots to  
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Figure 24. Screening of barcattKO mutant candidates by Southern blot 
The 5’ (A) and the 3’ (B) arms of barcattKO mutant candidates where tested by southern blot. Restriction 
enzymes used in each case and expected fragment sizes are as indicated on the schematics. Mutants 
are expected to have both a knock out allele and a wild type allele since the barcattKO should be 
homozygous lethal. Stocks for which both 5’ and 3’ arm were correct were selected for further analysis. 
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confirm candidates (Fig. 24A&B). The presence of the FRT sequence on the same 
chromosome as our mutant allele was confirmed by testing the ability of candidates to 
generate clones in the eye using ey-flp (Data not shown). Confirmed mutant candidates are 
called barcattPKO. 
 
We have generated a total of 11 barcattPKO mutant fly lines. Preliminary analysis of these 
mutants revealed that homozygous barcattPKO flies die prior to third instar larval stage, 
confirming that Barc is an essential protein for development. 
 
5.2.3.4. Design of two different rescue constructs 
In order to rule out that the lethality of homozygous barcattPKO flies is directly caused by the 
loss of barc and not a second site mutation, we generated attB-barc rescue constructs (Fig. 
25A&B). As mentioned earlier, the use of attP/attB sequences enables re-expression of Barc 
under the control of its own promoter (Fig. 25C-E). Having here the chance to generate useful 
tools for the analysis of barc, we have designed and prepared two different rescue constructs. 
 
barcRescueA contains a minimal attB sequence, non coding sequences deleted in the mutant 
(fragment of intron 1 + end of 5’UTR), and the coding sequence of barc fused to its 3’UTR 
(Fig. 25A). This construct will be used to test whether barcattPKO can be rescued. 
 
barcRescueB is similar to barcRescueA with the exception that the coding sequence of barc is 
tagged at its 3’ end with GFP, two cleavage sites (PreScission & TEV) and a BioTag, followed 
by the 3’UTR of the SV40 virus (Fig. 25B, for details refer to “Experimental Procedures”). 
BioTag is a motif that can be biotinylated by the E. coli biotin ligase BirA, allowing for protein 
pull-down using streptavidin beads (Schatz, 1993). The barcRescueB construct will be 
particularly useful to carry out biochemical experiments such as protein and chromatin 
immuprecipitations since, so far, our antibodies have proven unsuccessful at doing so. 
 
5.2.4. Study of the molecular function of Barc 
In parallel to making a mutant allele and two rescue constructs for barc, we started 
investigating the possible molecular functions of the protein. 
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Figure 25. Rescue constructs designed to rescue barcattKO mutants 
barcRescueA (A) contains the non coding sequences deleted in barcattKO (fragment of intron 1 + end of 
5’UTR), and the coding sequence of Barc fused to its 3’UTR. In barcRescueB (B), Barc is tagged with GFP, 
two cleavage sites, a BioTag, and is followed by the SV40 3’UTR. Theses rescue constructs are 
designed to rescue barcattKO mutants (C) via attB/attP recombination (D,E), and white is used as a 
selection marker. 
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5.2.4.1. The function of Barc does not require its second RRM 
We started our analysis by testing the importance of single domains of the protein in 
mediating its function. For that, we generated a series of six RNAi resistant constructs, lacking 
different parts of the protein (Fig. 26A). We have previously shown that Drosophila expressing 
UAS-barcRNAiGD under the control of insc-Gal4 die prior to adulthood, and that co-
expression of UAS-barcRes-FL rescues this lethality (Fig. 26A). We therefore decided to test our 
Barc deletion constructs for their ability to rescue the lethality associated with RNAi 
expression in neuroblast lineages. We reasoned that a construct lacking an essential domain 
of Barc would fail to rescue this lethality. 
 
We first tested constructs lacking fragments of the C-terminus. Surprisingly, barcRes-∆RRM2, a 
construct in which the second RRM and the very C-terminus are missing, was able to rescue 
the RNAi lethality, indicating that these two domains are dispensable for the function of Barc 
(Fig. 26A). However, barcRes-∆RRM1&2, in which both RRMs, the NLS and the very C-terminus 
have been removed, was unable to rescue lethality (Fig. 26A). This result is in agreement with 
our previous observation that this construct is unable to rescue the RNAi phenotype in larval 
brains (Fig. 16). However, because BarcRes-∆RRM1&2 lacks the NLS, the overexpressed truncated 
protein is mislocalized and can be found throughout the cell, when the endogenous protein is 
exclusively nuclear (Fig. 26B,B’,C,C’). To rule out that the inability of BarcRes-∆RRM1&2 to rescue 
barc RNAi-associated lethality, we used barcRes-nls-∆RRM1&2, a construct lacking the same 
domains as BarcRes-∆RRM1&2 but to which we added the SV40 NLS (Fig. 26A). We first tested the 
intracellular localization of BarcRes-nls-∆RRM1&2 and found that it localizes predominantly to the 
nucleus (Fig. 26D&D’). However, this construct was also unable to rescue barc RNAi 
lethality, indicating that Barc needs its first RRM to carry out its function. We then tested 
constructs lacking fragments of the N-terminus. Interestingly, all deletions affecting this part of 
the protein – as in barcRes-∆N, barcRes-∆BTS and barcRes-∆RRM1 – disrupted the function of Barc (Fig. 
26A). This result indicates that the N-terminus of Barc is important for the function of the 
protein. 
 
Taken together, these data suggest that the second RRM and the very C-terminus of Barc are 
dispensable for the main function of the protein, whereas all other domains are important, 
either because of a direct activity or because they allow the protein to adopt its appropriate 
3D structure. 
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Figure 26. Analysis of Barc domains 
(A) Scheme of the deletion constructs tested for their ability to rescue lethality associated with 
expression of barc GD RNAI with insc-Gal4>>CD8::GFP. Only the 2nd RRM of Barc is dispensable. (B-
D’) Close-up on neuroblasts expressing different barc constructs under the control of insc-Gal4: 
barcRes-FL::GFP (B,B’) is nuclear, barcRes-ΔRRM1&2::flag (C,C’) is mislocalized and myc::barcRes-nls-ΔRRM1&2 
(D,D’) is largely nuclear. 
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5.2.4.2. Barc associates with DNA 
The presence of RRMs in Barc as well as the function of human Tat-SF1 in transcription 
elongation, prompted us to determine whether Barc can associate with DNA in vivo. 
 
To test this, we decided to use larval salivary glands, a well-established model to test 
association of proteins with DNA in vivo. These glands are located in the vicinity of the larval 
brain, and their cells undergo several rounds of endoreplication to become polyploid (Fig. 
27A). Their polytene chromosomes show a reproducible, banded pattern when stained with 
DAPI (Fig. 27B&B’). DAPI weak bands, called interbands, correspond to open chromatin, and 
bright bands to packed chromatin. Most Drosophila genes have been mapped to a precise 
band or interband and conversely each band can be identified, allowing mapping protein 
binding on DNA. 
 
When we stained polytene chromosomes for Barc, we observed that the protein localizes in a 
specific pattern, colocalizing with most interbands and suggesting that it associates with 
decondensed DNA regions (Fig. 27C-D’). We then wanted to ask whether Barc is found in 
transcribed regions that undergo active elongation. To test this, we co-stained polytene 
chromosomes for Barc and for elongating polymerase II (Phospho-Serine 2 of its Carboxy-
terminal repeat), with a commercial antibody. Interestingly, we found that Barc largely 
overlaps with elongating polymerase II (Fig. 26E-H’). This expression pattern is very similar to 
the one of Spt5, a subunit of the DSIF complex, and of Spt6, another protein involved in 
transcription elongation (Kaplan et al., 2000; Andrulis et al., 2000; Ardehali et al., 2009). 
 
These observations suggest that Barc associates with DNA in vivo and that it could play a role 
in transcription elongation. 
 
5.2.4.3. Testing the function of Barc in elongation and splicing 
Given that Barc seems to associate with DNA and that its homologues Tat-SF1 and CUS2 
have been involved in transcription elongation and/or splicing, we wanted to test whether 
Barc regulates any of these two processes. To circumvent the difficulty of isolating a large 
number of neuroblasts from larval brains, we decided to use S2 cells, the best-established 
Drosophila cell culture model. 
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Figure 27. Barc associates with polytene chromosome 
(A) Schematic displaying the localization of salivary glands (SG) in Drosophila larvae. Polytene 
chromosomes are found in the cells of these glands. MH: Mouth hooks. OL: Optic lobe. CB: Central 
brain. VNC: Ventral nerve cord. (B-H’) Polytene chromosomes labeled with indicated markers. DAPI 
(B,B’,D,D’) marks areas corresponding to condensed DNA (bands) whereas Barc (C-D’) associates with 
decondensed regions (interbands). (E-H’) Barc (F,F’,H,H’) largely overlaps with elongating RNA 
polymerase II (phosphorylated on Serine 2 of its carboxyterminal domain, G-H’). 
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• Optimization of RNAi conditions in S2 cells 
After confirming that Barc is expressed in S2 cells, we worked on establishing optimal RNAi 
knock down conditions in this system (Fig. 28). A classical way to induce RNAi in S2 cells, is 
to serum-deprive cells and incubate them together with a double stranded fragment of RNA 
(dsRNA) of the gene of interest. This dsRNA enters the cells and is processed to trigger RNAi 
against this gene. 
 
As a control, we decided to use untreated cells and cells incubated with dsRNA against eGFP, 
a gene that is not expressed in S2 cells. eGFP dsRNA serves as a control for a possible effect 
of activating the S2 cell dsRNA-processing machinery. To target barc, we tested two different 
fragments of dsRNA: barc SD dsRNA and barc GD dsRNA (Fig. 28A). At the time we 
designed these constructs, barc SD dsRNA was predicted to be the most efficient dsRNA 
fragment by SnapDragon, a program dedicated to the generation of dsRNAs to induce RNAi 
in S2 cells (for details, see Experimental Procedures). The barc GD dsRNA corresponds to the 
fragment of barc mRNA that is targeted by the GD RNAi line. 
 
We first wanted to determine which of the two barc dsRNAs was more efficient. For that, we 
tested expression levels of barc relative to tubulin, three days after incubation with either no 
dsRNA or 15µg (per well of 6-well plates) of each dsRNA (Fig. 28B&C). As we expected, 
eGFP dsRNA had very little effect on Barc. However, SD and GD dsRNAs decreased Barc 
levels from 41% and 84%, respectively, compared to untreated cells. We then wanted to test 
whether incubating cells with 30µg of each dsRNA would increase the knock down efficiency 
(Fig. 28D&E). Similarly as when 15µg were used, eGFP dsRNA did not affect Barc. 
Interestingly, using 30µg of dsRNA did significantly increase the effect of the SD construct 
(from 41% with 15µg to 60% knock down with 30µg). However, doubling the amount of 
dsRNA, only slightly improved the GD-mediated knockdown (from 84% with 15µg, to 90% 
knock down with 30µg). Given these results, we decided to use the 20µg of barc GD dsRNA 
for our next experiments. 
 
To finalize the optimization of our S2 RNAi conditions, we wanted to test whether our GD 
dsRNA would be more efficient if cells were given more time to degrade Barc. For that, we 
incubated cells with 20µg of GD dsRNA, collected them after three, four or five days, and 
quantified relative levels of Barc compared to untreated cells that had been prepared in 
parallel (Fig. 28F&G). The result of this experiment was that waiting longer before collecting  
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Figure 28. Optimization of barc RNAi knock down in S2 cells 
(A) Schematic of the regions targeted by barc GD and SD dsRNAs. (B,D) Expression of Barc and 
Tubulin after a 3 days incubation with no dsRNA (UN: untreated cells), 15µg/well of 6-well plate (B), 
or 30µg/well of 6-well plate (D) of either dsRNA. (F) Expression of Barc and Tubulin after a 3,4 or 5 
days incubation with no dsRNA (UN: untreated cells) or 20µg/well of 6-well plate of barc GD dsRNA. 
(C,E,G) is the quantification of the western blots presented in (B,D,F) respectively. Expression of Barc 
relative to Tubulin. Values for cells treated with eGFP dsRNA, barc GD dsRNA and barc SD dsRNA are 
normalized to the value measured in untreated cells grown in parallel. 
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cells does not improve the efficiency of our GD dsRNA and that knock down is optimal after 
three days, at which point Barc is only expressed at about 16% of its level in untreated cells. 
 
• GRO-seq versus shcRNA-seq: Choice of the method and sample preparation 
Having established optimal barc RNAi conditions in S2 cells, we then had to choose the best 
method to test the role of barc in elongation and splicing. 
 
Two methods have recently been developed that enable to visualize PolII promoter-proximal 
pausing (PPP) and/or elongation at a genome-wide level: global run-on sequencing (GRO-
seq) and sequencing of short capped RNAs (shcRNA-seq) (Core et al., 2008; Nechaev et al., 
2010). 
 
GRO-seq is a method that requires incorporation of Br-UTP into newly synthesized RNAs by 
polymerase molecules engaged in transcription. Br-UTP-labeled mRNAs can then be purified 
using an antibody, and sequenced. The main advantage of this method is that it enables to 
compare the abundance of PPP polymerase compared to actively elongating polymerase, and 
that at each locus. However, because this technique involves isolation of nuclei, it requires a 
lot of starting material – about 5 million cells (Core et al., 2008). This is not a problem when 
working with S2 cells, but we were interested in using a method that could subsequently be 
used in neuroblasts.  
 
We therefore decided to use shcRNA-seq, which can be performed from less than a million 
cells. This method relies on isolation and sequencing of short capped RNAs associated with 
paused polymerases (Fig. 29). Additionally, if these shcRNAs are sequenced from their 3’ end, 
using specific adapters, it is possible to obtain resolution of polymerase PPP at the base pair 
level. To generate shcRNA libraries, we first isolated short RNAs from total RNAs. Because 
pausing happens in average around 35nt downstream from the transcription start site, we 
purified RNAs ranging from 25 to 120nt. We then 5’-digested uncapped RNAs – mRNAs 
being protected from digestion by their 7-methylguanylate cap (m7G). Short capped RNAs 
were then ligated to a 3’ ssRNA/DNA adapter, purified, decapped and ligated to a 5’ 
ssRNA/DNA adapter. Finally, a cDNA library was prepared from these purified shcRNAs. The 
disadvantage of this method, however, is that it only provides information about transcription 
state around the promoter. To circumvent that, and to be able to additionally test the role of 
Barc in splicing, we decided to prepare mRNA libraries in parallel to our shcRNA libraries. 
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Figure 29. Protocol used to prepare libraries of short capped RNAs from S2 cells 
Small RNAs are first selected from total RNAs by size. Then, uncapped RNAs are degraded and a 3’ 
adapter is ligated to small capped RNAs. After decapping, a 5’ adapter is ligated to small decapped 
RNAs and cDNA are prepared. Adapted from (Nechaev et al., 2010). 
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In summary, we treated S2 cells with either eGFP or barc GD dsRNA, collected cells after 3 
days, extracted total RNAs, and prepared an mRNA and a shcRNA library from each sample 
(Fig. 30). We repeated this whole experiment a second time to prepare a second set of 
libraries and we hope that sequencing them will enable us to determine the molecular 
function of Barc. 
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Figure 30. Scheme of the experiment to prepare short capped RNA and mRNA libraries. 
S2 cells were incubated with either eGFP dsRNA or barc GD dsRNA. After a few days growth, total 
RNAs were isolated and served to prepare libraries of short capped RNAs and mRNAs. The whole 
experiment was done in duplicates. 
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5.3. DISCUSSION 
5.3.1. Summary 
CG6049/barc was originally identified as an overproliferation gene in a recent neuroblast 
genome-wide RNAi screen (Neumuller et al., 2011). In this study, we have shown that barc 
encodes a broadly expressed nuclear protein that plays an important role in larval neuroblast 
lineages, and possibly other tissues as well. In type 2 lineages, Barc regulates maturation of 
INPs and seems to be especially important for re-expression of the transcription factor Dpn in 
immature INPs. In type 1 lineages, Barc is required to produce neurons. Additionally, Barc 
seems to regulate growth in both lineages. Given the fact that larval neuroblasts regrow 
between each division, it is possible that the growth defect observed upon loss of barc is 
connected to an alteration of the cell cycle. We have presented here how we generated a 
barc mutant allele that will allow us to precisely test effects of Barc on cell fate and cell cycle. 
 
We also designed experiments to determine how Barc regulates neuroblast lineages at the 
molecular level. We have for example shown that the main function of Barc is not mediated 
by its second RRM. Additionally, we have demonstrated that Barc associates with DNA in 
vivo. This observation, combined with the role of Tat-SF1 in regulating elongation, suggests 
that Barc could regulate neuroblast lineages by controlling transcription, possibly at the level 
of elongation. To test this and to assess a potential role of Barc in splicing, we have prepared 
shcRNA and mRNA libraries whose analysis should allow us to establish the molecular 
function of Barc. Additionally, we designed a tagged rescue construct that should enable the 
identification of binding partners of Barc as well as its binding pattern on DNA. It would be 
particularly interesting, for example, to determine whether Barc associates with all or a subset 
of actively transcribed loci. At the gene level, it would also be interesting to establish whether 
Barc is predominantly found around the promoter, where polymerase molecules pause, or 
whether it associates with elongating polymerases. 
 
5.3.2. Making INPs: Step by step 
Our data suggest that Barc is a novel regulator of INPs. We have shown that it is particularly 
important for immature INPs to progress to a mature INP stage. Interestingly, two transcription 
factors, PointedP1 (PntP1) and Earmuff (Erm), were recently shown to also affect INPs (Zhu et 
al., 2011; Weng et al., 2010). PntP1 is specifically expressed in type 2 lineages and its knock 
down leads to less INPs. This is probably due to the fact that it upregulates Ase in type 2 
neuroblasts. Conversely, ectopic expression of PntP1 in type 1 neuroblasts, triggers formation 
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of INPs in lineages that normally do not produce transit amplifying cells (Zhu et al., 2011). In 
erm mutants, INPs are correctly generated, progress to a mature Ase+Dpn+ state, and start 
producing GMCs. However, these mature INPs eventually dedifferentiate and revert back to 
neuroblast-like cells. These ectopic neuroblasts continue to proliferate and undergo ACD to 
produce INPs, resulting in an overproliferation situation. Erm has been proposed to control 
INP fate by regulating Pros and Notch signaling via a mechanism that remains elusive (Weng 
et al., 2010). 
 
It is interesting to note that although PntP1, Barc and Erm have an effect on INP fate, they all 
play different roles and a regulatory cascade can be resconstituted where PntP1 determines 
type 2 neuroblast identity, Barc regulates the progression from immature to mature INP 
stages, and Erm is required to maintain mature INP fate. 
 
5.3.3. Loss of Barc and tumor formation 
Knock down of barc in larval brains results, in type 2 lineages, in an accumulation of INPs at 
the expense of neurons. Most of these INPs are Ase+Dpn-, a stage at which cells are normally 
not dividing (Boone and Doe, 2008; Weng et al., 2010; Bayraktar et al., 2010). 
 
Interestingly, when pieces of barc RNAi brains are transplanted into the abdomen of wild-
type flies, they proliferate and are able to form tumors in about 30% of cases, whereas wild-
type brains never do so (Nidhi Saini & Heinrich Reichert, unpublished). Additionally, tumor 
cells from barc RNAi transplanted brains (traceable with GFP) can invade healthy tissues like 
ovaries, similarly to what has been described for mutants of several genes involved in ACD or 
affecting centrosomes (Nidhi Saini & Heinrich Reichert, unpublished) (Castellanos et al., 
2008; Woodhouse et al., 1998; Caussinus and Gonzalez, 2005). It would be interesting to 
determine whether barc tumors display chromosomal defects, like in mira, numb and pros 
tumor cells (Caussinus and Gonzalez, 2005). The frequency of tumor-formation with barc 
RNAi is lower than with brat RNAi, which leads to massive overproliferation in larval brains 
and to tumor formation in 90% of transplantation experiments. It is surprising, however, that 
although barc knock down does not trigger a clear neuroblast overproliferation in situ it is 
able to generate tumors upon allograft transplantation. The exact mechanism behind this 
observation remains unclear, but three possibilities seem particularly likely. 
 
First of all, barc deficient cells could require a latency phase, prior to undergoing massive 
proliferation. The larval brain is a rapidly evolving tissue and larval neuroblasts stop dividing 
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and disappear in early pupal stages. It is possible that transplantation into the abdomen of an 
adult fly offers barc RNAi cells the time to bypass the developmental constrains of the larval 
brain and to achieve their transformation into tumor cells. Secondly, it is possible that tumor 
formation upon barc knock down is prevented in the larval brain by the glial sheath that 
surrounds each neuroblast lineage (Doe, 2008). The contact between the glial sheath and 
neuroblasts is important for proliferation. In fact, its disruption by overexpression in glia of a 
dominant negative form of the adhesion protein E-cadherin results in reduced proliferation of 
neuroblasts (Dumstrei et al., 2003). This could be caused by the alteration of either the 
brain/hemolymph barrier or direct signaling between glia and neuroblasts. Glial cells are also 
able to inhibit the proliferation of neuroblasts during early larval stages, by secreting 
Anachronism (Ana) (Ebens et al., 1993). Given the fact that glial cells play a dual role in the 
regulation of proliferation, it is possible to conceive that alteration of the glial sheath upon 
transplantation is responsible for the barc tumor formation. Finally, it is possible that signals 
present in the abdomen of the host are responsible for the ultimate transformation of barc 
deficient cells into tumor cells. 
 
The discrepancy between the barc RNAi phenotype in larval brains and the capacity of these 
brains to form tumors upon transplantation is not unprecedented. In fact, pins, which 
regulates spindle orientation in neuroblasts follows the same pattern as barc. Larval brains 
mutants for pins have fewer and smaller neuroblasts, however, upon transplantation they 
form large, invasive tumors that present chromosomal defects (Lee et al., 2006b; Caussinus 
and Gonzalez, 2005). A recent study demonstrated that pins mutant brains can form tumors 
in larval brains upon either food deprivation, inhibition of target of rapamycin (TOR) or 
reduced phosphatidylinositol 3-kinase (PI3K) activity (Rossi and Gonzalez, 2011). 
Interestingly, these three conditions enhanced the efficiency of pins mutant brains to form 
tumors in the abdomen of host flies, whereas they were unable to trigger tumor formation in a 
wild-type background. This study suggests that a set of signals acts in the larval brain to 
suppress overgrowth of compromised cells. A similar mechanism could explain why barc 
RNAi brains are able to form tumors upon allograft transplantation even though their 
neuroblasts do not overproliferate in situ. 
 
5.3.4. The Barc/Tat-SF1/CUS2 family of proteins: functional evolution? 
As mentioned earlier, the human protein Tat-SF1 plays a role in splicing and transcription 
elongation, whereas its yeast homologue, CUS2, is only known to be involved in splicing. 
This observation, taken together with the structural differences between CUS2 and Tat-SF1, 
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raises the interesting hypothesis that the structure and the function of members of this family 
of proteins evolved in parallel. 
 
CUS2 and Tat-SF1 share a core structure composed of two RRMs and a NLS. The first RRM of 
both proteins has been shown to be essential for their function (Fong and Zhou, 2001; Yan et 
al., 1998). Compared to CUS2, Tat-SF1 has two additional domains: a short N-terminus and 
long C-terminus. The short N-terminus, contains a BTS motif that has been shown to bind 
CA150, a protein that bridges transcription and splicing, and that could play a role in 
recruiting Tat-SF1 to elongating polymerase (Smith et al., 2004). The long acidic C-terminus is 
essential for binding to CyclinT1, a subunit of P-TEFb (Fong and Zhou, 2001). Additionally, 
Tat-SF1 has been shown to interact with the DSIF complex and the Paf1 complex (Paf1C); 
Tat-SF1/DSIF/Paf1C binding cooperatively to RNA Pol II to stimulate transcription elongation 
(Chen et al., 2009; Kim et al., 1999). However, the protein domain of Tat-SF1 engaged in 
these interactions remains unknown. 
 
Structural evolution of Tat-SF1 seems to have enabled acquisition of novel functions in 
transcription elongation. In this context, it is particularly interesting to note that RNA pol II 
promoter-proximal pausing has not been observed in S. cerevisae where complexes involved 
in pausing, such as NELF, have not been identified (Radonjic et al., 2005; Nechaev and 
Adelman, 2010). It is tempting to think that the structure of Tat-SF1 is adapted to the 
regulatory mechanism controlling elongation. 
 
In terms of structural evolution, Barc seems to be an intermediate step between CUS2 and 
Tat-SF1. Indeed, Barc has a longer N-terminus than Tat-SF1 but does not have a long C-
terminal extension. Similarly to Tat-SF1, the N-terminus of Barc contains a BTS motif that 
could allow it to interact with polymerase. The fact that the BTS domain is also present in 
Arabidopsis thaliana suggests that it was lost in yeast rather than gained in all other 
eukaryotes. Interestingly, the N-terminus of Barc is longer than that of Tat-SF1 and we have 
shown in this study that this extension is important for the function of the protein. Its precise 
role is yet unknown and could be of two kinds: It could be the functional equivalent of the C-
terminus domain of Tat-SF1, or alternatively, it could have taken on a novel role. 
 
5.3.5. Transcriptional elongation and regulation of neuroblast lineages 
Over the last couple of years, mounting evidence has accumulated demonstrating that 
polymerase pausing is important for development in higher eukaryotes. Indeed, a very large 
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fraction of genes regulating development harbor paused polymerases, both in Drosophila 
embryos and in mouse ES cells (Rahl et al., 2010; Zeitlinger et al., 2007). Supporting this, 
NELF knock down-mediated abrogation of pausing leads to developmental defects in mouse 
ES cells, as well as in Drosophila (Amleh et al., 2009; Haley et al., 2008; Wang et al., 2010). 
Additionally, presence of paused polymerases has been recently shown to maintain an open 
chromatin state and prevent from these promoters to be occupied by nucleosomes (Gilchrist 
et al., 2010). Conceptually, polymerase pausing is now considered to maintain a “ready to go 
state” that would allow for tight regulation of genes that need to be rapidly activated or 
repressed, either during development or in response to a stimulus. 
 
RNA Pol II promoter-proximal pausing and its release should be considered as a multilayered 
process. The first layer is composed of the core pausing/elongating machinery. Protein 
complexes such as NELF, DSIF, P-TEFb and Paf1C would fall in this category and their knock 
down in neuroblast lineages would be expected to affect most genes. In fact, in the neuroblast 
RNAi screen, knock down of subunits of DSIF, NELF, Paf1C or P-TEFb, led to 
underproliferation (Neumuller et al., 2011). Although the specificity of each RNAi line has 
not been specifically assessed, it seems that affecting these protein complexes inhibits cell 
cycle and/or promotes apoptosis. The second layer is composed of genes that release pausing 
at specific loci and/or under certain conditions. In Drosophila, such genes have not yet been 
identified, and in vertebrates only few examples have been described. For example, it was 
recently shown that in mouse ES cells c-Myc acts on its target genes by interacting with P-
TEFb and releasing polymerase pausing, rather than by recruiting polymerase to their 
promoter (Rahl et al., 2010). Additionally, in the Zebrafish Danio rerio, moonshine – the 
orthologue of human Tif1γ – has been shown to regulate hematopoiesis by controlling 
transcription elongation at genes required to specify erythroid cell fate (Bai et al., 2010). A 
model has been proposed, in which blood-specific transcription complexes interact with 
Tif1γ that, in turn, recruits positive elongation factors, such as P-TEFb and the FACT complex, 
to blood genes. 
 
It remains to be clearly demonstrated that Drosophila barc acts on elongation, and whether it 
plays a role at a large number of loci or if it regulates a restricted number of genes. 
Interestingly, the phenotype observed upon barc RNAi knock down is different from the one 
observed for components of the core pausing/elongating machinery. Remarkably, four other 
genes play a role in transcription elongation and lead to a phenotype similar to barc RNAi 
knock down in larval brains: ssrp, a subunit of the FACT complex, and brm/osa/mor, three 
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members the Brm complex (Neumuller et al., 2011). Both complexes have been shown to 
promote transcription elongation by destabilizing nucleosomes (Schwabish and Struhl, 2007; 
Belotserkovskaya et al., 2004). Further studies should enable to determine whether barc 
regulates transcription elongation in a general or a specific manner, and whether barc 
regulates larval neuroblast lineages via a similar or a different mechanism than 
ssrp/brm/osa/mor. 
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5.4. EXPERIMENTAL PROCEDURES 
Fly stocks 
UAS-Dicer-2; insc-Gal4, UAS-CD8::GFP/CyO (Neumuller et al., 2011) 
UAS-Dicer-2; wor-Gal4, ase-Gal80; UAS-CD8::GFP (Neumuller et al., 2011) 
UAS-barcRNAiGD (TID25497, Vienna Drosophila Stock Center) 
UASt-barricadeRes-FL ; UAS-barcRNAiCustom (Neumuller et al., 2011) 
UASt-barricadeRes-FL::eGFP; UASt-eGFP::barricadeRes-FL; UASt-6xMyc::barricadeRes-FL; 
UASt-barricadeRes-FL::6xMyc; UASt-3xFLAG::barricadeRes-FL; UASt-barricadeRes-FL::3xFLAG; 
UASt-3xFLAG::barricadeRes-∆RRM2; UASt-barricadeRes-∆RRM2::3xFLAG; 
UASt-barricadeRes-∆RRM1&2; UASt-barricadeRes-∆RRM1&2::3xFLAG; 
UASt-barricadeRes-nls-∆RRM1&2; UASt-3xFLAG::barricadeRes-nls-∆RRM1&2; 
UASt-6xMyc::barricadeRes-nls-∆RRM1&2; UASt-barricadeRes-∆N; 
UASt-barricadeRes-∆BTS; UASt-barricadeRes-∆RRM1. 
 
Cloning of UAS constructs 
All UASt-barricade constructs were cloned from a plasmid containing the coding sequence of 
barricade that is resistant to UAS-barcRNAiGD and was published in (Neumuller et al., 2011). 
We used the Gateway system to clone the following DNA fragments in pDONOR221. 
Gateway attB sequences are underlined. 
 
Full lenght (amino acids 1 to 556): 
Upstream: 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGAGCGACGAAGGTGGCTG-3’ 
Downstream: 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAAGGGGTGGCGTCTCCTG-3’ (Stop) or 5’-
GGGGACCACTTTGTACAAGAAAGCTGGGTCAGGGGTGGCGTCTCCTGGCA-3’ (No Stop). 
 
∆RRM2 (amino acids 1 to 415): 
Upstream: 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGAGCGACGAAGGTGGCTG-3’ 
Downstream: 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCTATTTCTCATTCTTTGACCGTTCGC-3’ (Stop) 
or 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCTTTCTCATTCTTTGACCGTTCGC-3’ (No Stop). 
 
∆RRM1&2 (amino acids 1 to 284): 
Upstream: 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGAGCGACGAAGGTGGCTG-3’ 
Downstream: 
5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAGGTGTTCTGCAATGGATCCATTTCG-3’ (Stop) or 
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5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCGGTGTTCTGCAATGGATCCATTTCG-3’ (No Stop). 
 
nls-∆RRM1&2 (nls sequence from SV40, followed by amino acids 1 to 284): 
Upstream: 5’-
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGACTGCTCCAAAGAAGAAGCGTAAGAGCGACGAAGGTGG
CTG-3’ (SV40 nls) 
Downstream: 
5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAGGTGTTCTGCAATGGATCCATTTCG-3’ (Stop). 
 
∆N (amino acids 173 to 556): 
Upstream: 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGAACACGGGGAACGAACCTATAC-3’ 
Downstream: 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAAGGGGTGGCGTCTCCTG-3’ (Stop). 
 
∆BTS (amino acids 281 to 556): 
Upstream: 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGTTGCAGAACACCAAGGTGTATG-3’ 
Downstream: 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAAGGGGTGGCGTCTCCTG-3’ (Stop). 
 
∆RRM1 (amino acids 366 to 556): 
Upstream: 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGAGGGCTCAGTTCCAAATGCGTG-3’ 
Downstream: 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAAGGGGTGGCGTCTCCTG-3’ (Stop). 
 
Donor vectors containing the above fragments were recombined onto the appropriate 
destination vectors. Final destination vectors were used to generate transgenic flies using 
standard P-element transformation. 
 
Generation of an attP barricade knock-out 
A deletion of 1424bp containing the first two coding exons of barricade and a part of each 
flanking intron was generated by ends-out homologous recombination (for description of the 
general method and vectors, see (Huang et al., 2009)). 
 
The upstream homology arm (with respect to the orientation of the gene) of 4015bp was 
amplified using the following primers: 5’-GATCGCGGCCGCTACCCATTTTATAGACTTCC-3’ 
(NotI) and 5’-GATCGGTACCCGTGAAACAACAAAACTAAATTGC-3’ (KpnI). 
 
The downstream homology arm of 4777bp was amplified using the following primers: 
5’-GATCGGCGCGCCTTTAGTTTTATTCGCTTTTCATTTC-3’ (AscI) 
and 5’-GATCCTGCAGCTTGTTAGAGGCTTCTCCGACAT-3’ (PstI). 
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These DNA fragments were amplified from a pNB61 vector containing a longer upstream arm 
and the same downstream arm than the ones described above (donated by Ralph Neumueller 
and Constance Richter). 
 
Both arms were cloned in pGX-attP using NotI/KpnI for the upstream arm and AscI/PstI for the 
downstream arm, to generate pGX-barcattP (final mutants are called barcattPKO). Subsequent fly 
work was done essentially as described in (Huang et al., 2009). 
 
Correct recombination of the homology arms was screened by PCR and by Southern blot 
using a standard protocol. Restriction enzymes used to digest DNA fragments were AhdI and 
ApaI (Upstream arm) or BsiWI and BamHI (Downstream arm). 
Primers used to amplify the upstream probe (also called 5’ probe): 5’-
CACGACATGCTCATCTTGGG-3’ and 5’-CGCAAGAATATTGCTTTGAACGCT-3’ 
Primers used to amplify the downstream probe (also called 3’ probe): 5’-
TGGGCCCAATACACGGGAAAATACTTT-3’ and 5’-AAGTTCCATATCTACCGGCA-3’ 
 
Generation of attB barricade rescue constructs 
Rescue A (barcRescueA) 
The end of the first intron (deleted in barcattPKO) and the beginning of the first coding exon 
were cloned from genomic DNA using 5’-GATCGCATGCTGGTGATTATTTGTTGTCCTG-3’ 
(SphI) and 5’-CAGCCACCTTCGTCGCTCATTTTGCGTTCTGTAATTAAAGC-3’. 
The coding sequence of barc was cloned from a vector containing barc cDNA using 5’-
GCTTTAATTACAGAACGCAAAATGAGCGACGAAGGTGGCTG-3’ 
and 5’-GATCACTAGTCTAAGGGGTGGCGTCTCCTG-3’ (SpeI). 
 
These two fragments were mixed and a PCR was done using: 
5’-GATCGCATGCTGGTGATTATTTGTTGTCCTG-3’ (SphI) 
and 5’-GATCACTAGTCTAAGGGGTGGCGTCTCCTG-3’ (SpeI). 
 
barc 3’UTR was cloned from pGX-barcattP using: 
5’-GATCACTAGTTTTTCATTTACCTGCGATCGTTTTC-3’ (SpeI) 
and 5’-GATCGGTACCGACAAAAACGCCAATCTTACAGAGC-3’ (KpnI). 
This fragment was ligated with the previous one after digestion with SpeI. This rescue 
construct was cloned in pGE-attB-GMR using SphI/KpnI to generate pGE-barcRescueA. 
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Rescue B (barcRescueB) 
The end of the first intron and the coding sequence of barc was cloned from pGE-barcRescueA 
using 5’-GATCGCATGCTGGTGATTATTTGTTGTCCTGG-3’ (SphI) 
and 5’-GATCACTAGTAGGGGTGGCGTCTCCTGGCAA-3’ (SpeI). 
 
A DNA fragment containing the coding sequence of GFP, a PreScission clivage site, a TEV 
clivage site, a Biotin acceptor tag (Schatz, 1993) and the SV40 3’UTR was amplified from a 
vector donated by the Brennecke Lab using: 
5’-GATCACTAGTGGCGGCGGCGTGAGCAAGGGCGA-3’ (SpeI) 
and 5’-GATCGGTACCGGATCCAGACATGATAAGATAC-3’ (KpnI). 
 
These two fragments were ligated together after digestion with SpeI. This rescue construct was 
cloned in pGE-attB-GMR using SphI/KpnI to generate pGE-barcRescueB. 
 
Antibodies and immunohistochemistry 
Antibodies used in this study are rabbit anti-Mira (1:100, (Betschinger et al., 2006)), rat anti-
Mira (1:100), mouse anti-Pros (1:10, Developmental Studies Hybridoma Bank, University of 
Iowa [DSHB]), guinea pig anti-Ase (1:100, (Bhalerao et al., 2005)), guinea pig anti-Dpn 
(1:1000, gift from J. Skeath), mouse anti-PhosphoH3 (1:1000 Cell Signaling Technology), 
mouse anti-Ser2-phosphorylated CTD of Pol II (1:50 H5 monoclonal, Covance), rat anti-Elav 
(1:300 [DSHB]), mouse anti-Elav (1:100, Developmental Studies Hybridoma Bank, University 
of Iowa [DSHB]), mouse anti-FasIII (1:10, Developmental Studies Hybridoma Bank, 
University of Iowa [DSHB]), mouse anti-c-Myc (1:1000, Santa Cruz Bio- technology). Barc 
specific antisera were generated in rabbits (Neumuller et al., 2011) and guinea pigs (this 
study) against the C-terminal peptide: MKEEDVDSPENQLLPGDATP. Cortical actin was 
visualized using rhodamine Phalloidin (Molecular Probes) or Alexa 488 Phalloidin (Molecular 
Probes). Secondary antibodies were conjugated to Alexa 405, Alexa 488, Alexa 568 and 
Alexa 633 (Molecular Probes) or Cy5 (Jackson Immunofluorescence). 
 
Larval brains were dissected in PBS and fixed in 5% PFA, 0,1% Triton-X100 in PBS for 20 
minutes at room temperature. Embryos of the appropriate stage were collected and 
dechorionated using a standard protocol and fixed in 5% FA for 20 minutes at room 
temperature. Ovaries and testes were dissected in PBS and fixed in 4% FA, 0.2% Triton X-100 
in PBS for 20 minutes at room temperature. Stainings of larval brains, ovaries and testes were 
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done following a standard protocol. Polytene stainings were done using third instar female 
larvae grown at 18ºC. Preparation and staining of polytene chromosomes were done 
essentially as described in (Paro, 2008). All samples were mounted in Vectashield (with or 
without DAPI), and imaged using a ZEISS LSM confocal microscope. 
 
dsRNA generation 
eGFP: A DNA fragment of 495bp (base pairs 65 to 569 of the coding sequence of eGFP) 
flanked by T7 promoter sequences was generated using the following primers: 
5’-TAATACGACTCACTATAGGGACGTAAACGGCCACAAGTTC-3’ 
and 5’-TAATACGACTCACTATAGGGTGTTCTGCTGGTAGTGGTCG-3’ (T7 promoter). 
 
Barc GD: A DNA fragment of 342bp (base pairs 173 to 514 of the coding sequence of 
barricade) flanked by T7 promoter sequences, was generated using the following primers: 
5’-TAATACGACTCACTATAGGGCGGACAAAACGGACGAAACTCCA-3’ 
and 5’-TAATACGACTCACTATAGGGCCACACCGCAAACCCCTTCC-3’ (T7 promoter). 
This fragment corresponds to the one used to generate the VDRC TID25497. 
 
Barricade SD: A DNA fragment of 491bp (base pairs 224 to 714 of the coding sequence of 
barricade) flanked by T7 promoter sequences, was generated using the following primers: 
5’-TAATACGACTCACTATAGGGACATGACCTATGGAGCGGAC-3’ 
and 5’-TAATACGACTCACTATAGGGCTCCTCCTTTCTCTTGGCCT-3’ (T7 promoter). 
This fragment corresponded to the first prediction of the dsRNA design program SnapDragon 
when we designed it. SnapDragon: http://www.flyrnai.org/cgi-bin/RNAi_find_primers.pl. 
RNAi efficiency was tested by western blots, which were quantified using Image J. 
 
S2 cells culture conditions 
Drosophila S2 cells were cultured at 27˚C in M3+BPYE media (Shields and Sang’s M3 media, 
0,25% bactopeptone, 0,1% Yeast extract) supplemented with 10% heat-inactivated bovine 
serum (HBS). 
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RNAi in S2 cells 
Cells were grown to a density of 3 to 5x106 cells/ml at 27˚C in 75cm3 flasks. They were then 
centrifuged for 4 minutes at 400g and resuspended at 1,5 x 106 cells/ml in M3+BPYE media 
without serum. 5ml of cells were placed in a 75cm3 flask with the appropriate amount of 
dsRNA and incubated for 45 minutes at room temperature. 5ml of M3+BPYE media 
supplemented with 20% HBS was then added to each flask and cells were incubated at 27˚C. 
After the appropriate amount of days, proteins were extracted with laemmli buffer using 
standard conditions and total RNAs were extracted using a standard Trizol extraction 
protocol. 
 
Preparation of short capped RNA (shcRNA) libraries 
Short-capped RNA libraries were prepared from 15 to 20µg of total RNA (10µl). Total RNAs 
were mixed with 10µl of formamide loadding buffer, heated for 5 minutes at 65˚C and 
separated on a 15% Urea-PAGE gel that had pre-run for 15-30 min in TBE at 200V. A ssRNA 
ladder and a miRNA ladder were used to estimate the size of RNAs. The gel was run at 200V 
for 1 hour and stained with ethidium bromide. 
 
The portion of the gel containing RNAs ranging from 25 to 120 bases was cut and placed in a 
0,5ml tube pierced several times with a 22-gauge needle and placed in a 2ml tube. Gel 
fragments were crushed by centrifugation for 2 minutes at maximum speed. 400µl of 300mM 
NaCl were added on the gel slurry and samples were incubated for 4 hours at room 
temperature on a rapidly rotating wheel. Samples were then transferred to a 0,22µm spin filter 
column and centrifuged for 2 minutes at 1000g. One microliter of glycoblue and 2,5 volumes 
of ethanol were added to the eluate and RNA was precipitated at −80˚C for at least 30 
minutes. After centrifugation for 30 minutes at maximum speed, pellets were washed with 
70% ethanol and resuspended in 17µl of DEPC-treated water. 
 
The 5’ end of uncapped transcripts was dephosporylated by adding 2µl of 10X buffer for 5’ 
polyphosphatase, 1µl of 5’ polyphosphatase enzyme and incubating reactions at 37˚C for 30 
minutes. Reactions were stopped by adding 80µl of phenol/chloroform/isoamyl alcohol and 
80µl of DEPC-treated water, extracted with 60µl of chloroform and RNA in the water phase 
was precipitated for 30 minutes at −80˚C after adding 1/10 volume of 5M NaCl, 1µl of 
glycoblue, and 2,5 volumes of ethanol. After pellet centrifugation and washing as described 
above, RNA was resuspended in 17µl of DEPC-treated water. 
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Uncapped transcripts were degraded by adding 2µl of 10x buffer for 5’ Terminator 
exonuclease, 1µl of 5’ Terminator nuclease and incubating the reaction at 30˚C for 1 hour. 
Reactions were stopped with phenol/choloroform, extracted with chloroform and precipitated 
with ethanol as described above and resuspended in 6,4µl of DEPC-treated water. 
 
3’ adaptor ligation was done by adding 0,6µl of a 1/150 dilution of LLi3’ adaptor (Stock 
solution: 1mM in TE pH 7,0), 1µl of RNAse inhibitor, 1µl of 10x buffer for ssRNA ligase 1, 1µl 
of T4 ssRNA ligase 1 and incubating reactions for 6 hours at 20˚C. 
 
RNA fragments were prepared and separated on a 15% Urea-PAGE gel as described above. 
Gel fragments containing RNA molecules between 50 and 150 bases were cut and RNA was 
extracted from these fragments and precipitated as described above. RNA was resuspended in 
17µl of DEPC-treated water. 
 
Excess 3’ adaptors were dephosporylated by adding 2 µl of 10x Heat Labile Alkaline 
Phosphatase buffer, 1 µl of Heat Labile Alkaline Phosphatase and incubation at 37˚C for 10 
minutes. Reactions were stopped and RNA precipitated as described above. RNA was 
resuspended in 44µl of DEPC-treated water. 
 
Decapping of RNA fragments was done by adding 5µl of 10x buffer for Tobacco Acid 
Pyrophosphatase, 1ul Tobacco Acid Pyrophosphatase and incubation at 37˚C for 1,5 hours. 
Reactions were stopped and RNA precipitated as described above. RNA was resuspended in 
5,7µl of DEPC-treated water. 
 
5’ adaptor ligation was done by adding 1,3µl of a 1/150 dilution of LLi5’ adaptor (Stock 
solution: 1mM in TE pH 7,0), 1µl of RNAse inhibitor, 1µl of 10x buffer for ssRNA ligase 1, 1µl 
of T4 ssRNA ligase 1 and incubating reactions for 6 hours at 20˚C. 
 
RNA fragments were prepared and separated on a 10% Urea-PAGE gel as described above. 
Gel fragments containing RNA molecules between 75 and 175 bases were cut and RNA was 
extracted from these fragments and precipitated as described above. RNA was resuspended in 
4,5µl of DEPC-treated water. 
 
Prior to performing the RT reaction, samples were mixed with 0.5 µl of GX1 primer, 
incubated at 65˚C for 10 minutes and placed immediately on ice. Then, 4µl of RT mix (2 μl of 
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5xSSRT buffer, 1 μl of DTT, 0.5 μl of RNAse inhibitor, 0.5 μl of 12.5mM dNTP mix) was 
added, samples were incubated at 3 minutes at 48˚C and 1µl of SSRT II enzyme was added 
before incubation at 44˚C for 1 hour.  
 
PCR reaction was performed by adding 40 µl of PCR mix (10 µl of 5x Phusion PCR buffer HF, 
0.5 µl of 25mM dNTP mix, 0.5 µl of GX1, 0.5 µl of GX2, 0.5 µl Phusion DNA polymerase) 
and using the following PCR program: 
1 cycle of: 98°C  – 30s 
16-17 cycles of: 98°C   - 12s; 60°C   - 30s; 72°C  – 15s  
1 cycle of: 72°C  – 10 min 
 
DNA fragments were mixed with 6x DNA loading dye and separated on a 6% TBE gel, 
alongside 10µl of Gene Ruler 100bp DNA ladder. The gel was run in 1xTBE at 200V for 20-
30 minutes. Gel fragments containing DNA molecules between 100 and 200 bp were cut and 
DNA was extracted from these fragments with 400µl of elution buffer supplemented with 
50mM of NaCl at room temperature for 2 hours. The supernatant was filtered as described 
above and DNA was precipitated with 40µl of 3M NaAcetate, 1 µl of glycoblue and 1ml of 
ethanol. The DNA was immediately centrifuged for 30 minutes at maximum speed. Pellets 
were washed with 70% ethanol and resuspended in 100µl of elution buffer. DNA libraries 
were purified using Qiagen MinElute kit, eluted with 17µl of elution buffer and their 
concentration measured with Nanodrop spectrophotometer or Picogreen. These libraries will 
be sequenced using a HiSeq2000 or a GAIIx machine and a standard protocol. 
 
Primers and adapters for shcRNA libraries: 
LLi3' 5’-/5Phos/rGrArUCGTCGGACTGTAGAACTCTGAACT/3InvdT/-3’ 
LLi5' 5’-ACAAGCAGAAGACGGCATArCrGrA-3’ 
GX1 5’-AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA-3’ 
GX2 5’-CAAGCAGAAGACGGCATACGA-3’ 
 
Preparation of messenger RNA libraries 
mRNA libraries were prepared from 7 to 10µg of total RNA (5µl). Total RNAs were mixed 
with 20µl of DEPC-treated water, heated for 5 minutes at 65˚C and immediately placed on 
ice. To remove rRNAs, total RNAs were purified using Dynabeads oligo(dT)25 beads as 
follow. Prior to purification, an aliquot of 50µl of Dynabeads oligo(dT)25 beads was washed 
twice with 50µl of binding buffer. Beads were pelleted using a magnet and resuspended is 
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25µl of binding buffer. Samples were incubated together with these beads for 5 minutes at 
room temperature. After discarding the supernatant, the beads were washed twice with 50µl 
of washing buffer, resuspended in 10µl of 10mM Tris-HCl and incubated 2 minutes at 80˚C. 
After this incubation, the supernatant was immediately transferred to 40µl of binding buffer 
and the beads were discarded. mRNAs were purified a second time using another aliquot of 
50µl of Dynabeads oligo(dT)25 beads as described above except that this time, the final 
supernatant was mixed with 30µl of DEPC-treated water and 10µl of 5x fragmentation buffer. 
Samples were then heated for 2,5 minutes at 94˚C and mixed with 50µl of DEPC-treated 
water, 10µl NaAc, 1µl Glycoblue, 250µl of 100% EtOH and incubated overnight at −20˚C. 
After centrifugation for 1 hour at maximum speed, pellets were washed with 70% ethanol and 
resuspended in 8µl of DEPC-treated water. 
 
The first strand of cDNA was synthesized as follow. Samples were mixed with 1µl of random 
primers (3µg/µl) and 1µl of dNTP mix (10mM each) and heated for 5 minutes at 65˚C. After 
chilling on ice, samples were mixed with 2µl of 10x RT buffer, 4µl 25mM MgCl2, 2µl 0,1 M 
DTT, 1µl RNAse OUT, 1µl of Superscript III and were incubated 10 minutes at 25˚C, 50 
minutes at 50˚C and 5 minutes at 85˚C. After chilling on ice, samples were mixed with 10µl 
DEPC-treated water, 3µl 4M NaCl, 90µl 100% EtOH and were incubated overnight at −20˚C. 
 
The second strand of cDNA was synthesized as follow. After centrifugation for 1 hour at 
maximum speed, pellets were washed twice with 70% ethanol and resuspended in 50µl of 
water. Samples were then mixed with 20µl 5x second strand buffer, 1µl random primers 
(3µg/µl), 0,2µl 100mM dATP, 0,2µl 100mM dCTP, 0,2µl 100mM dGTP, 0,2µl 100mM dUTP, 
2,66µl DNA PolI, 0,66µl DNA ligase, 0,66µl RNAse H and 24,22µl water. These samples 
were then incubated 2 hours at 16˚C. cDNA libraries were purified using Qiagen MinElute kit 
and their concentration was measured with Nanodrop spectrophotometer or Picogreen. 
Adaptors compatible with Illumina paired-end sequencing were ligated following a standard 
protocol and these libraries will be sequenced using a HiSeq2000 or a GAIIx machine. 
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The genome-wide RNAi screen that identified CG6049/barricade and briefly described its 
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was donated by Ralph Neumueller and Constance Richter. Generation of the barc knock out 
and screening of candidates was done with assistance from Peter Duchek. Southern blots 
presented in figure 24 were done by Elke Kleiner. The rest of this chapter was contributed by 
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